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   Hypomorphic mutations of the DKC1 gene cause the X-
linked dyskeratosis congenita, an inherited multisystemic disorder 
characterized by a variety of symptoms, including mucocutaneous features, 
stem cell dysfunction, bone marrow failure, and increased susceptibility to 
cancer. DKC1 encodes an evolutionarily conserved protein, called dyskerin, 
whose activity is essential for cellular vitality. Dyskerin participates in at least 
two functional ribonucleoprotein (RNP) complexes that play essential roles in 
the cell. The protein is in fact an essential component of H/ACA snoRNPs, 
which are involved in the processing and pseudouridylation of rRNAs. In 
addition, through its binding to the telomerase RNA component (TERC), that 
contains an H/ACA RNA motif, dyskerin participates in the active complex of 
telomerase, ensuring telomeres stability and maintenance.  
In order to investigate and characterize in more detail the effects triggered by 
DKC1 loss of function on human cells, we generated a stable cellular model 
able to reduce gene expression, upon inducible RNA interference, without 
affecting the expression of the alternatively spliced cytoplasmic isofom 3.  
I focussed my analyses on the effects triggered by dyskerin depletion well 
before telomere erosion, in order to define the spectrum of telomere-
independent outcomes. Intriguingly, I found that dyskerin depletion affected 
cell adhesion. In fact, dyskerin dowregulation perturbed both cell-cell and cell-
substrate adhesion, causing reduced expression of some proteins involved in 
the tight and adherens junctions, and in the focal adhesions. Moreover, co-
immunoprecipitations analyses revealed interactions between dyskerin and 
some component of focal adhesions, while confocal microscopy indicates that 
this interaction can occur at level of the plasma membrane. Finally, I observed 
that dyskerin depletion alter cell morphology and increases cell motility. 
Altogether, these results could be of valuable help to understanding the 

















1.BACKGROUND                                                                                                  
1.1 Dyskeratosis congenita: symptoms and transmission manner 
 
   Dyskeratosis congenita or Zinsser-Cole-Engman 
syndrome is a rare disorder that embraces a variety of symptoms including 
hyperpigmentation, skin atrophy, nail dystrophy and mucosal leukoplakia (for 
a review Kirwan and Dokal 2009).(Fig.1). 
Figure1: Main phenotypic traits of DC patients (DC): mucosal leucoplakia (a), ungueal dystrophy (b), 
anomalous pigmentation of the skin (c), cerebral hypoplasia (d), premature hair graying (e). From Kirwan 
and Dokal, 2009. 
It is now known that this characteristic symptomatology is coupled to a series 
of additional symptoms such as mental retardation, premature aging and bone 
marrow failure. The latter represents the main cause of early death, although 
DC patients are more disposed to the development of lung diseases and 
malignant neoplasms, which may also be fatal (Mason and Bessler. 2011). The 
syndrome exhibit genetic heterogeneity, with three kinds of inheritance modes: 
Autosomal Dominant (AD-DC), Autosomal Recessive (AR-DC) and X linked 
recessive (X-DC). The X-linked form is due to hypomorphic mutations of 
DKC1 gene (Heiss et al. 1998) located on the long arm of the X chromosome at 
the locus 28. Many mutations affecting the DKC1 gene have been so far 
identified, including an in frame triplet deletion (201-203 CTT) that causes the 
lost of the aminoacid leucin 37 (Heiss et al. 1998); a ~2 kb (kilo bases) 
chromosomal deletion that causes the loss of exon 15 and the use of a cryptic 
polyadenilation signal (Vulliamy et al. 1999); a single mutation into the 
promoter region (-141; C→G) that disrupts a binding site of the transcription 
factor SP1, thus affecting the basal level of the promoter (Knight et al. 1999); a 
mutation in intron 1 (IVS1+592; C→G), that generates a cryptic donor splice 
site which induces the incorporation into the mature transcript of 246 intronic 
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bases that interrupt the CDS and generate a non functional transcript (Knight et 
al. 2001). 
The autosomal dominant forms, which collect about 10% of clinical cases 
(Cossu et al. 2002), generally show a more attenuated and delayed clinical 
picture and exhibit genetic "anticipation", a phenomenon in which the 
phenotype’s severity increases in subsequent generations, so that the disease is 
manifested earlier from generation to generation. Three causative genes have 
been identified: TERC, the telomerase RNA component (Vulliamy et al. 2001); 
TINF2, which encodes for a protein present in the "shelterin" complex involved 
in telomere maintenance (Savage et al. 2008) and TERT, that encodes for the 
telomerase reverse transcriptase component (Armanios et al. 2005). Finally, the 
autosomal recessive variant, which is present in 5% of clinical cases (Cossu F. 
2002), is caused by mutations in the genes encoding for the nucleolar proteins 
Nop10 and Nhp2, which associate to telomerase and have an essential role also 
in the maintenance of snoRNA of H/ACA class and in pre-rRNA maturation. 
The X-linked form is undoubtedly the most widespread, grouping about 80% 
of clinical cases (Cossu et al. 2002). The causative gene, DKC1, was identified 
in 1998, when a screening of cDNA from different patients identified 
mutations in its coding region (Heiss et al. 1998). 
 
1.2 DKC1 and its orthologs   
 
   The human DKC1 gene encodes a nucleolar protein of 58 
kDa, called dyskerin, whose sequence is phylogenetically highly conserved. In 
fact, dyskerin has orthologs in yeast (Cbf5), rat (Nap57) and Drosophila 
(NOP60B / minifly). The Cbf5 yeast gene, originally identified as a binding 
factor of centromeres and microtubules (Jiang et al. 1993), was the first 
member of this genes family to be identified. Cbf5 is an essential gene that 
encodes a protein containing a domain composed of ten KKE/D repetitions 
arranged in tandem. These repeats, are homologous to portions of the domain 
responsible of microtubule binding (Noble et al. 1989). Later it was 
demonstrated that CBF5 is a pseudouridine synthase responsible to the rRNA 
pseudouridylation (Lafontaine et al. 1998). In fact, it presents a considerable 
sequence homology with the pseudouridine synthase TruBp of E. coli and 
shares sequence motifs conserved "KP" and "XLD" present in the catalytic 
domains of three distinct families of pseudouridine synthase. In line with the 
bacterial TruBp, the XDL motif of Cbf5 contains an aspartate at position 95, 
essential for its pseudouridylation activity and its replacement with an alanine 
abolishes the rRNA pseudouridylation in vivo (Zebarjadan et al. 1999). In 
addition, the inactivation of Cbf5 gene turns out to be lethal because it creates 
defects in the processing and pseudouridylation of rRNAs precursors (Cardwell 
et al. 1997; Zebarjadian et al. 1999) Finally, it was also observed a CBF5 
involvement in the cell cycle, through its  KKE / KKD motif at the C-terminal. 
In particular, W. Jiang et al. (1993) noted that the complete deletion of the 
Cbf5 gene, led to cell cycle arrest in G1 / S phase, whereas cells containing a 
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C-terminal truncated CBF5 gene, producing a protein containing only three 
copies of the KKD/E repeat, delay with replicated genomes at the G/M phase 
of the cell cycle.                                                                                            
The dyskerin mammalian homolog, Nap57, is involved in the nucleus-
cytoplasm shuttling of pre-ribosomal structures (Meier and Blobel. 1994). The 
Drosophila homologue gene, called NOP60B / minifly (Philips et al. 1998 ) is 
essential for the rRNAs precursors maturation and pseudouridylation. His 
absence is lethal, while a reduction of its espression entails pleiotropic effects 
such as lower body size, feminine infertility and developmental delay 
(Giordano et al. 1999). Subsequently, studies in primary cells obtained from 
patients with X-DC and from DKC1 knock-out or mutant mice (carrying the 
same mutations found in human patients) unrevealed that the disease is 
accompanied by a reduction of telomeres length (Mitchell et al. 1999; 
Vulliamy et al. 2001). However, in transgenic mice the symptoms manifested 
many generations before the telomeres underwent a real shortening, supporting 
the idea that reduced levels of protein synthesis and pseudouridylation played a 
more important role in the pathogenesis of X-DC. He et al. (2002) created two 
Cre/LoxP transgenic mice carrying two different allelic variants of the DKC1 
gene. In particular, one mouse carried a large deletion that eliminated the 12-15 
exon region, and the other one carried a deletion of the only exon 15 designed 
to produce a truncated dyskerin protein similar to that found in a DC patients. 
Females heterozygous for both deletions showed a complete embryonic 
lethality from day 9.5 post conception (d.p.c.). At day 7.5 d.p.c., no male 
embryo was vital, while female embryos showed degeneration of extra 
embryonic tissues. Since in these tissues the paternal X chromosome is 
inactivated, this suggested the occurrence of a maternal effect, so far still 
unexplained at the molecular level. Moreover, heterozygous females in which 
the deletion was of paternal origin had a strong tendency to selectively 
inactivate the mutant chromosome, retaining the wild type chromosome active 
in all cells. Since X chromosome inactivation is a very early event in 
embryonic development, this skewed inactivation pattern is likely to result 
from a “cell competition” mechanism, by which cells that inactivated the wild-
type chromosome were strongly disadvantaged, and then competed-out by cells 
actively expressing the wild type X chromosome. Moreover, recreating the last 
exon deletion, thus resulting in a truncated protein lacking 21 aa, there was 
observed a growth rate reduction associated with an accumulation of reactive 
oxygen species (ROS). An increase in ROS, examined through the 
phosphorylation of H2AX, an indicator of DNA damage, can result from 
ribosomal stress caused by the perturbation of ribosome biogenesis  (Gu et al. 
2013). Once indentified DKC1 as X-DC responsible gene, it is passed to the 
description all related orthologs present in plants, fungi, protists and archaea 
(Watanabe and Gray. 2000; Maceluch et al. 2001; Lin and Momany. 2003). 
The importance of these proteins for the cell life is demonstrated by the 
observation that in all examined organisms null mutations are lethal, while 
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ipomorfic mutations or gene silencing cause a number of phenotypic 
abnormalities (Giordano et al. 1999; Tortoriello et al. 2010; Zhang et al. 2012). 
 
1.3 DKC1 and dyskerin structure   
 
    The DKC1 gene consists of 15 exons and hosts two 
H/ACA snoRNAs (small nucleolar RNAs), named ACA36 and ACA56, in 
intron 8 and 12, respectively. The snoRNA ACA36 drives the 
pseudouridylation of U105 and U1244 residue of 18S rRNA, whereas the 
snoRNA ACA56, allows the U1664 28S rRNA residue pseudouridylation. 
Moreover, ACA56 is known to act as a micro RNA (miRNA) precursor (Ender 
et al. 2008). In addition to the canonical transcript encoding dyskerin and the 
known alternative transcript which directs the synthesis of a truncated dyskerin 
variant with cytoplasmic localization, called isoform 3 (Angrisani et al. 2011), 
our research group has identified others 3 alternative transcripts.  These new 
isoform, called isoform 4, 5 and 6, respectively, are characterized by total or 
partial retention of a specific intron and could encode proteins that lack the 
PUA domain, essential for the binding to the RNA, or the nuclear localization 





Figure 2. Structure of intron-retaining hDKC1 transcripts. On the top, the structure of the 2.6 kb 
hDKC1 mRNA (iso 1) encoding canonical dyskerin (GenBank ID: NM_001363). Exons are depicted as 
boxes, coding regions are in black; the position of the main dyskerin functional domains is indicated 
above, together with that of the intronically encoded SNORA36A and SNORA56. Below, structures of 
the ESTs marked with # and their related transcripts, as derived by RT-PCR cloning  and nucleotide 
analysis.(From Turano et al.2013) 
 
The transcripts expression was confirmed in both different cell lines and 
normal tissue with a variation of their expression levels, suggesting that DKC1 
isoforms may contribute to the gene functional diversity across different cell 
types. Since all new transcripts were characterized by premature stop codons 
(PTCs), to exclude that the new isoforms could be under the NMD surveillance 
mechanism which commits such mRNAs to the degradation, the expression of 
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these transcript was analysed in cells (colorectal adenocarcinoma) treated and 
not treated with cycloheximide, an inhibitor of protein synthesis that represses 
NMD. DKC1 isoforms containing PTC are resulted unaffected by the 
treatment. Finally, to evaluate the isoforms coding potential, it was checked the 
accumulation of the RNA isoforms in both the cytosolic and nuclear fractions. 
We found the isoforms 4 and 5 essentially retained in the nuclei, while isoform 
6, together with canonical isoform 1, was efficiently exported in the cytoplasm 
suggesting a possible translation (Fig.3).(Turano et al. 2013). 
 
      
 
The sequence alignment of dyskerins from different organisms has revealed the 
presence of highly conserved regions which reflects their functional 
conservation. This aspect was directly attested by swapping experiments, 
which showed that Drosophila and rat dyskerin were both able to rescue yeast 
Cbf5 mutations (Phillips et al. 1998; Yang et al. 2000). The protein structure in 
mature form proposed by the Pfam database (DKC1_HUMAN) identifies the 
presence of three conserved functional domains: the first, known as dyskerin 
like Domain (DKLD; 48-106 aa), whose function is currently unknown; the 
second, known as domain TruB_N, (110-226 aa), is the pseudouridine synthase 
catalytic domain and contains the active site directly involved in the 
pseudouridylation process; the third, the PUA RNA binding domain, (297-370 
aa) is involved in the recognition of the RNA of H/ ACA family (Figure 4). 
Figure 3.Comparative estimate 
of the levels reached by each 
new hDKC1 isoform in nuclear 
and cytosolic fractions. (A) 
Abundance of each isoform was 
determined by qRT-PCR 
analysis; the snoRNA SNORA62 
was used as a nuclear marker, 
while GSS mRNA was used as 
marker of the cytosolic fraction. 
Expression was normalized with 
respect to POLR2A mRNA. (B) 
Agarose gel of 800 ng 
fractionated RNA; M 1 kb DNA 
ladder(Applichem), N nuclear 
RNA, C Cytoplasmic RNA. (C) 
Semiquantitative RT-PCR of 
SNORA62 nucleolar RNA; M 
100 bp Plus DNA 
ladder(Applichem), N nuclear, C 




The protein exhibit also two nuclear localization signals (NLS), characterized 




Figure 4. Dyskerin structure and sequence conservation. A) Organization of Dyskerin functional 
domains. The red boxes at N- and at C terminal ends represents the NLS (nuclear localization signals). 
The purple  box represents the DKCLD domain. The TruB_N e PUA domains  are respectively in blu and 
in green. Multiple allignament of terminal sequence N- (B) e C- (C) of dyskerin derived from different 
organisms (Da Angrisani et al., 2014). 
Many post translational modification of human dyskerin have been annotated 
in the UniProt database. These modifications show a different degree of 
phylogenetic conservation, with the elimination of initiator methionine and N-
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acetylation of residue 2, characteristic of eukaryota, with a few exceptions in 
unicellular organisms, and phosphorylation of serines 21, 451, 453, 455, 485, 
494, 513 and of threonine 458, and sumoylation of lysines 16, 39, 46 and 448 
evolutively preserved. Dyskerin modification by SUMO1 and SUMO2/3, 
firstly revealed by high-through put mass spectrometry experiments at four 
residues (Manza et al. 2004; Blomster et al. 2009; Westman et al. 2010), has 
recently been directly confirmed by Brault et al. (2013). These authors also 
provided a direct correlation between pathologic mutations and sumoylation 
defects. Looking at protein sequence, the divergence main points observed 
between eukaryotic and archaeal dyskerins are located at the N- and C-
terminal, where the eukaryotic proteins have a typical extension (Figure 2B and 
C). An interesting aspect is that the N-terminal extension length is greater in 
metazoans; where stands a block retained about 30 amino acids (2-34 in 
humans), absent in the yeast proteins. Probably, even if it has not been defined 
yet, this portion has a regulatory function and this hypothesis is supported by 
the fact that it is subjected to two post-transcriptional modifications: the 
sumoylation of lysine 16 and the phosphorylation of serine 21 (Angrisani et al. 
2014).  
 
1.4 Dyskerin functions    
 
   All eukaryotic diskerins described so far have mainly a 
nuclear localization. Inside the nucleus, dyskerin participates in three 
essential complexes (Fig. 5): the H/ACA small nucleolar ribonucleoparticles 
(snoRNPs) (Kiss et al. 2006), the telomerase holoenzyme (Cohen et al. 2007) 
and the specific Cajal body ribonucleoparticles (scaRNPs).  
The H/ACA snoRNPs are hetero-pentameric complexes in which dyskerin is 
associated with a molecule of small nucleolar RNA (snoRNA) of H/ACA 
class and three highly conserved proteins: NOP10, NHP2 and GAR1 (Kiss et 
al. 2006). Nascent H/ACA snoRNAs are mainly intronic and the assembly of 
the H/ACA snoRNP complexes occurs before the host intron is spliced out 
from the primary transcript (Richard et al. 2006). While the association of 
snoRNA with Gar1p, Nop10p, Nhp2p is only transitory, the dyskerin-
snoRNA association is irreversible and settled during the snoRNA maturation 
(Kittur et al. 2006). In addition is known that the Naf1 protein is essential for 
the biogenesis of  H/ACA snoRNP (Dez et al. 2002; Fatica et al. 2002). In 
fact, in yeast this protein participates in the early steps of the RNPs 
assembling and it has been found associated with snoRNA genes 
transcriptionally active, while did not show any interaction with the mature 
snoRNP particles (Ballarino et al. 2005). Similar results were also highlighted 
in human cells by Kittur et al. (2006) who proposed that, during the 
maturation of snoRNP, Naf1 is replaced by Gar1 protein, and this assures that 
the mature particle is released from the transcription site of snoRNA and 






Figure 5: Dyskerin nuclear complex. The three complexes are localized in the nucleus, where they are 
involved in different functions. While snoRNA complexes direct the re-RNA process, those with 
canonical snoRNA direct the RNA pseudouridylation. When dyskerin associates with orphans RNA of 
H/ACA class, with unknown targets,unlike , the result complexes could guide the cell RNA modification 
or act as precursor of regulator RNA small (miRNA/dsRNA). At least, if it associates with scaRNA, the 
tetramer  dyskerin -NOP10-NHP2-GAR1 forms the scaRNP, localized in the Cajal bodies, where direct 
the RNA pseudouridylation. (Angrisani et al. 2014). 
 
The typical secondary structure of H/ACA snoRNAs is composed of two 
hairpins and two short single stranded sequences containing, respectively, the 
H (ANANNA) and ACA boxes, with the latter always localized 3 nucleotides 
upstream the snoRNA3’end (Fig.6A). Hairpin structures are interrupted by 
recognition loops containing the guide sequences; within the region of base 
pair complementarity to the target RNA, the first unpaired nucleotide 
represents the uridine that will be modified. The inner ring of single-stranded 
(often referred to as the pocket pseudouridylation) is always located 14-16 
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Figure 6: H/ACA snoRNA Structure. 
A) Schematic representation of a canonical 
H/ACA snoRNA molecule   
B) Site of pseudouridylation, located 14-16 nt 
upstream  the box 
nucleotides upstream the H or the ACA box.(FIG.6B). The most common 
targets of snoRNPs pseudouridylation are represented by rRNAs and snRNAs, 
and correct pseudouridylation of these molecules seems to be necessary for 
their proper functionality and for efficient ribosome biogenesis. The main 
function of these complexes is to catalyze the pseudouridylation of new 
synthesized RNA ribosomal. 
The snoRNA, therefore, acts as a 
guide selecting, by sequence 
complementary, the RNA target and 
the specific residue to be 
pseudouridilated (Lafontaine and 
Tollervey. 1998). In this process 
dyskerin, is the pseudouridine 
synthase that directs the conversion of 
uridine into pseudouridine. Since the 
most common targets of 
pseudouridylation are stable RNA, 
that play a key role in basic cellular 
processes such as rRNA and snRNAs, 
where residues pseudouridilated are 
often found in functional highly 
conserved positions (Maden. 1990; 
Yu et al. 2011; Ge and Yu. 2013), it 
was easy to predict that the uridine 
isomerization into pseudouridine 
could modulate gene expression in a 
variety of manners. Since for a 
growing number of snoRNAs, 
indicated as “orphan”, has not been 
identified any RNA target, other 
cellular RNAs could be subject to pseudouridylation. Intriguingly, many 
snoRNA “orphans” show a tissue specific expression pattern, as it is the case of 
HBI-36, a snoRNA specifically expressed in the brain, at the level of the 
choroid plexus (Cavaillé et al. 2000). Although pseudouridylation represents 
the most common modification found on cellular RNAs, its biological role is 
still elusive. Pseudouridines are able to form hydrogen bridges with bases other 
than adenine, and its presence can influence folding and activity of stable 
RNAs, like tRNAs, rRNAs and snRNAs (Arnez and Steitz. 1994; Newby and 
Greenbaum 2002), and also affect their interaction with RNA-binding proteins.      
Unlike for the ribosome structure, it was previously suggested that this modify 
not only contributes to the rRNA folding and ribosomal subunits assembly, but 
could also influence the efficiency of the codon translation and recognition 
(Luzzatto and Karadimitris. 1998). In the ribosomes biogenesis, dyskerin not 
only plays an important role in the pseudouridylation reaction, but it is also 
involved in the maturation of pre-rRNA, through nucleolytic cuts guided by the 
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H/ACA snoRNAs U17 (also called E1), E2 and E3. For the 5' maturation of 
the18S rRNA is, in fact, request the function, probably as a chaperone, of the 
snoRNA U17, which in humans present two isoforms, the U17A and U17b. 
The snoRNA E2 is necessary for the 3 'end  maturation of the same rRNA, 
whereas the snoRNA E3 is required for the 5' maturation of the 5.8S rRNA. 
The rRNA pseudouridylation is highly conserved during evolution, but it is not 
the only role played by dyskerin. Due to its ability to bind the RNA component 
of telomerase (TERC), dyskerin also participates in telomerase holoenzyme 
assembly in Cajal bodies, playing an important role in maintaining the 
telomeres integrity. Telomeres are composed of about a thousand copies of a 
short sequence repeat rich in G (in humans the telomeric sequence is 5'-
TTAGGG-3 '), which protrude from the end, forming a single-stranded 
telomeric and shorten to each replication cycle due to the DNA polymerase 
inability to replicate the linear DNA molecules ends (Machado-Pinilla et al. 
2008). This progressive telomeres erosion is countered by telomerase which 
mediates the synthesis of telomeric repetitive sequences of DNA as a template 
using TERC, a snoRNA molecule of H/ACA class. Cohen et al. (2007) 
identified dyskerin as essential component of the complex. In fact, although 
there are at least 32 other proteins associated to the telomerase complex none 
of these, except dyskerin, was proved to be necessary for the catalytic activity . 
It is still unknown how dyskerin mutations lead to a telomeres shortening, but 
both in mouse and in human cells has been observed that they lead to lower 
TERC levels (Wong and Collins. 2006; Mochizuki et al. 2004). Presumably 
these reduced levels of TERC are not sufficient to maintain telomere length in 
the stem cells that give rise to blood, skin and other tissues renewable, causing 
the shortening of the same and, finally, the stem cells depletion. This simple 
scheme is supported by the fact that the stem cells, in contrast to somatic cells, 
have an active telomerase and that the DC is a progressive disease that worsens 
with age .                                                                                                                 
The tissues most affected in DC, at least in its classical form, tend to be those 
that require a constant renewal of stem cells, such as blood, skin, nails, etc. 
(Mason and Bessler. 2011). It is noteworthy that novel functions have been 
hypothesized for the snoRNP (small nucleolar ribonucleoprotein) complexes in 
the last years. In fact, several reports indicated that H/ACA snoRNAs can act 
as precursors of miRNAs, a feature that appears to be largely widespread in 
eukaryotes. SnoRNA-derived miRNAs have in fact been described so far in 
Protozoa (Saraiya and Wang. 2008), humans (Ender et al. 2008), mouse, 
Arabidopsis, yeast, chicken (Taft et al. 2009) and Drosophila (Jung et al. 
2010). Moreover, the percentage of snoRNAs able to be processed into 
miRNAs has been estimated to range from 60% in humans and mouse to more 
than 90% in Arabidopsis. Although the snoRNA-miRNA processing 
mechanism is mostly unclear, it appears to be Dicer-1-dependent but 
Drosha/DCGR8-independent (Ender et al. 2008; Taft et al. 2009). Considering 
that miRNAs play a fundamental role in post-transcriptional gene regulation 
(for a review, see Fabian et al. 2010), it is plausible that pseudouridine synthase 
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depletion may widely affect developmental processes by inhibiting the 
snoRNA-derived miRNA regulatory pathway. Indeed, the occurrence of a large 
variety of developmental defects has recently been described in Drosophila as 
consequence of pseudouridine synthase gene silencing (Tortoriello et al. 2010). 
It is thus tempting to suggest that this mechanism might possibly account, at 
least in part, for the plethora of manifestations displayed by X-DC. Consistent 
with this hypothesis, dyskerin reduction has been recently shown to impair in 
an unpredictable way the biogenesis of snoRNA-derived miRNAs, allowing a 
huge spectrum of possible effects in conditions in which the expression of 
DKC1 is perturbed (Alawi and Lin 2010). 
 
1.5 Dyskerin and cancer 
 
The involvement of dyskerin in cell proliferation was 
discovered in 1992 when Dokal et al. observed that primary skin fibroblasts 
cultures derived from DC patients were abnormal both in morphology and 
proliferative rate (doubling time about twice normal) compared to control cells. 
Since then, it was assumed that the reduced levels of dyskerin perturbs the cell 
cycle progression and proliferation. In particular it has been observed an arrest 
in the G2/ M phase in yeast cells with Cbf5 mutated (Jiang et al. 1993), in cells  
dyskerin depleted (Alawi and Lin. 2011, 2013), in fibroblasts from patients X-
DC (Carrillo et al. 2013), and in mouse embryonic fibroblasts characterized by 
the expression of a catalytically inactive dyskerin (Gu et al. 2013). Therefore 
dyskerin depletion causes a reduction of cell proliferation, but this is in contrast 
with the increased predisposition to cancer observed in patients with X-DC. 
Cumulatively, the incidence of cancer in X-DC patients was reported about 
40% -50% by the age of 50 years (Alter. 2009).                                           
The fact that cell proliferation is related to nucleolar functions is demonstrated 
by the evidence that people affected by abnormal production of ribosomes, 
have a high predisposition to develop the cancer. Because of the metabolic 
demand, in fact, the proliferating cells are characterized by a demand increase 
of protein synthesis and the rate of ribosomes biosynthesis (Montanaro et al. 
2010). Consequently, dyskerin mutated cells show ribosomes defects and thus 
a low degree of proliferation (Derenzini et al. 2005). On the other hand, owing 
to the nature of DNA replication, the cells in active proliferation need to have 
telomerase well functioning to prevent the telomeres shortening and, 
consequently, an activation of DNA damage mechanism (Chan et al. 2004) 
Since the modification sites are located within specific domains of the 
ribosome, important for tRNA and mRNA binding, the decrease of the 
modified uridine residues in the ribosome, may result in an impairment of 
specific mRNA playing a key role in cancer (Yoon et al. 2006; Bellodi et al. 
2010; Montanaro et al. 2010; Rocchi et al. 2013). These mRNAs can be 
translated through the both classic translational mechanism and an IRES-
dependent translation mechanism, such those encoding the p27 apoptotic 
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protein and the antiapoptotic factors XIAP and Bcl-2. Although active in 
physiological conditions, IRES-dependent translation plays a key role in the 
response to apoptotic stimuli and during G0 / G1 cell cycle phase in which the 
cap-dependent translation is reduced. The authors suggested that the level of 
rRNA pseudouridylation could affect the ability of the ribosome to recognize 
highly structured IRESs, a key step for the cap-independent translation.Further 
information was recently added by Rocchi et al. (2013) who assayed the 
translation efficiency of a pool of viral and cellular IRESs in DKC1 silenced 
breast cancer cell lines. These authors observed that p53 and CrPV IRES-
mediated translation were reduced, while c-myc, HCV and EMCV IRES-
dependent translation were unaffected. Furthermore, VEGF and HSP70 IRES-
mediated translation were upregulated. These results lead to conclude that the 
level of ribosome pseudouridylation can differently modulate IRES-dependent 
translation: expression of some specific mRNAs could be repressed, while that 
of others be either unaffected or upregulated .                                                       
It is important also to note that the over-expression of dyskerin is involved in 
certain types of cancer, including colorectal cancer (Turano et al. 2008; 
Witkowska et al. 2010), breast cancer (Montanaro et al. 2006, 2008), prostate 
cancer (Sieron et al. 2009), ovarian cancer (Schaner et al. 2003), melanoma 
(McDonald et al. 2004), neuroblastoma (Westermann et al. 2007), lymphoma 
(Piva et al. 2006), and hepatocellular carcinoma (Liu et al. 2012), suggesting 
that the protein could be an important proliferative signal of tumor cells. In 
fact, several reports have shown a significant correlation between the increase 
of dyskerin level and advanced clinical stage (Montanaro et al. 2006; Sieron et 
al. 2009; Witkowska et al. 2010; Liu et al. 2012) , suggesting that the amount 
of the protein could be used as a prognostic marker, at least in some tumors 
although the precise mechanisms underlying dyskerin over-expression in tumor 
progression remains to be fully defined. 
 
 
1.6 Focal adhesions 
 
   The adhesion of cells to the extracellular matrix is the 
key to the regulation of cell morphology, migration, proliferation, survival and 
differentiation (Gumbiner et al. 1996). These functions are essential during the 
development, in the tissues maintenance and in the induction of tissues repair. 
Integrins are the predominant receptors that mediate cells adhesion to the 
components of the extracellular matrix (ECM). They are expressed on the cell 
surface as a heterodimer consisting of α and β subunits. Integrin subunits are 
type I transmembrane proteins containing both a large extracellular domain 
responsible for binding to ECM ligands and a cytoplasmic portion (CP) 
recruiting multiple intracellular proteins (Fig.7). The extracellular domains are 
responsible for ligands binding, while the cytoplasmic domains form multi-
molecular complexes providing a connection to the cytoskeleton (Hynes, 
2002). In this way, the exterior and interior of the cell are physically connected, 
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and this allows the bidirectional transmission of mechanical and biochemical 
signals across the plasma membrane, and leads to a cooperative regulation of 
different cellular functions, including adhesion, migration, growth and 
differentiation (Qin et al. 2004). So each integrin recognizes a distinct ligand 
on the cell surface and the cytoplasmic portions act as a platform for the 
recruitment of cellular proteins such as scaffold and signal proteins to the inner 





Figure 7: Integrins mediate cell adhesion to the extracellular matrix: They work as hetero dimers α 
and β; the cytoplasmic portion recruit signaling proteins and the actin cytoskeleton. Adapted from M. 
Nagano et al; 2011 
 
The protein scaffolds of focal adhesions such as: talin, paxillin,tensin, and the 
α-actinin, provide strong bonds to the actin cytoskeleton, and thus firmly 
connect the cells to the ECM (Humphries et al; 2007). This binding allows the 
generation of the voltage required to change the cell morphology and the 
tensile force required to move the cell body during the migration. In addition, 
more signaling proteins, including kinases and phosphatases, are recruited 
where they transmit signals that control the proliferation, survival and cell 
migration. In particular, two well characterized tyrosine kinases, such as focal 
adhesion kinase (FAK) and Src play a central role in signaling cascades 
mediated by integrin, transmitting signals from the FA to the cellular 
machinery by phosphorylating multiple proteins associated with integrins 
(Mitra and Schlaepfer 2006), since integrins have no intrinsic enzymatic 
activity. Integrins clustering leads to the rapid recruitment of FAK to the focal 
adhesion complex and its concurrent phosphorylation on tyrosine (Parsons and 
Parsons, 1997). FAK is “activated” by its phosphorylated on tyrosine 397 
(Tyr397), a major site of phosphorylation (Schaller et al. 1994). This correlates 
with increased catalytic activity of FAK (Calalb et al. 1995; Lipfert et al. 
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1992), and also creates a high affinity binding site recognized by the SH2 
domain of Src family kinases and leads to the recruitment and activation of Src 
through the formation of a bipartite kinase complex. ( Schaller et al.1994). 
Activation of the FAK-Src complex is central to regulation of down-stream 
signaling pathways that control cell spreading, cell movement and cell survival. 
The process of cell adhesion to the ECM has been studied by seeding cells onto 
an ECM-coated substratum in culture (Vlodavsky ET AL.1980) . These 
analyses contributed to the elucidation of the process of the initial attachment 
of cells to the ECM and the formation of integrin-mediated cell adhesion 
structures. However, cells must also detach from the ECM during migration, 
and the mechanism and regulation of the disassembly of cell adhesion 
structures is less well studied. (Vlodavsky, and Gospodarowicz. 1980): The 
stimulation of the FA complexes formation improves the adhesion of cells to 
the ECM, giving rise to cells with a flattened morphology. On the contrary, the 
FA destabilization reduces the adhesion to ECM and gives rise to a spherical 





Figure 8:Training and turnover of focal adhesions. Training and turnover is crucial for cell adhesion 
and cell migration. Adapted from M. Nagano et al; 2012. 
 
During the cells migration on a substrate, the focal adhesions bind strongly the 
matrix so as to generate the necessary forces to pull the cell body forward. 
Subsequently, the cells must release the ECM, so as to continue the movement 
of the cells. As such, the directional migration of the cell requires continuous 
training of FAs to the front edge of the cell body and the release of this tie in 
the back. The integrins clustering is the initial step of cell adhesion and is 
stabilized to form FAs linking actin stress fibers in a process regulated by Rho / 
ROCK. In contrast, the extension of the microtubules to the FAs triggers their 
disassembly and induces the subsequent internalization from the cell surface 
integrin. Therefore, the formation and turnover of FAs are regulated by 
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different mechanisms. Although the fate of the internalized integrins has not 
yet been elucidated, several studies have reported that once internalized, 
integrins are predominantly recycled back to the plasma membrane, although a 
fraction of α5β1 integrin has been shown to traffic to lysosomes for 
degradation during migration. Following endocytosis, integrins travel to early 
endosomes from which they can either be returned directly to the plasma 
membrane in a Rab4-dependent manner or further trafficked to the perinuclear 
recycling compartment (PNRC) before recycling through Rab11-dependent 
mechanis (Sejeong Shin et al. 2011). 
Among protein scaffold the paxillin plays an important role in the focal 
adhesion. Its name, derived from the Latin paxillus, a stake or peg, is consistent 
with its proposed function in linking actin filaments to integrin cell adhesion 
sites. Paxillin is one of the first protein that is found in focal adhesions rising to 
the front edge of the cell, where it is quickly arranged (Digman et al. 2008), 
suggesting an important role in promoting the assembly of accessions and in 
defining their molecular composition. Many authors report that during the 
formation of new focal adhesions paxillin is particularly enriched at the 
periphery of these small adhesions point (Zimerman et al. 2004) where paxillin 
seems to interact with vinculin, providing a link with the cortical actin at the 
leading edge of the cell. 
Alpha-actinin is a major component involved in microfilament stabilization 
and in linking microfilaments to adherens junctions, influencing microfilament 
organization and/or cell adhesion and motility. In addition to its structural role 
as a crosslinker of actin filaments, α-actinin is known to serve as a platform for 
a number of protein-protein interactions within the cytoskeletal organization 
(reviewed in Otey and Carpen. 2004). Evolutionary analysis, in fact, suggests 
that this protein best resembles the ancestral proteins of the spectrin 
superfamily, which is characterized by ubiquitously conserved spectrin repeats 
(SRs) and found in a large variety of taxa (Virel and Backma. 2004).  
Recent study suggest new roles for this protein, played not at focal adhesion or 
adherens junctions level, but in the nucleus. Zhao X et al. (2015), reported α-
actinin 4 involved in the NF-κB transcriptional regulation. In particular, 
interacting wth p65 and p50 in the nucleus, it is recruited to the promoters of 
NF-κB target genes regulating the expression of genes encoding pro-
inflammatory cytokines such as IL-1β and IL-8,3. chemokines and adhesion 
molecules In addition, by mass-spectrometry Khotin MG et al, (2009) have 
detected in nuclear complexes with alpha-actinin-4, protein such β-actin, α- 
and β-tubulins, ribonucleoprotein which regulates splicing, peroxiredoxin-1, 
which is involved in oxidative stress, and glycolytic enzyme D-3-
phosphoglycerate dehydrogenase, suggesting a possible role in the 







1.7 Tight junctions  
 
   Tight junctions (TJ) govern the permeability of epithelial 
and endothelial cells and are the most typical structures of these cell types (S. 
Tsukita et al 1999). They are regions where the plasma membrane of adjacent 
cells forms a series of contacts that appear to completely occlude the 
extracellular space thus creating an intercellular barrier and an intramembrane 
diffusion fence (V. Wong, et al. 1997). Briefly, the TJ has a characteristic 
structure, appearing as discrete sites of fusion between the outer plasma 
membrane of adjacent cells. TJ completely circumscribe the apices of the cells 
as a network of intramembrane fibrils appearing as what is generally described 
as a series of “kissing” points. The molecular components of the TJ have been 
extensively investigated (A.S. Fanning et al.1999) and could be reasonably 
separated into 3 regions: (i) the integral transmembrane proteins — occludin, 
claudins and junctional adhesion molecules (JAM), together with other CTX 
family members; (ii) the peripheral or plaque anchoring proteins, often 
containing PDZ motifs — zonula occludens (ZO)-1, -2, -3, MAGI-1 etc.; and 





Figure 9:Tight junctions (TJs)structure. TJs contain at least four major groups of transmembrane 
proteins: the JAMs, claudins, occludin and a number of cytoplasmic peripheral proteins. While the 
transmembrane proteins mediate cell-to-cell adhesion, the cytosolic TJ complex connects to different 
factors (e.g. ZO-1/-2/-3, MUPP1 or cingulin) that link the involved transmembrane proteins to the actin-
cytoskeleton. (Modified by Backert et al. 2013) 
 
In epithelial cells the TJ prevent cell dissociation (F. Hollande et al. 2001) and 
their expression may be modulated by growth factors, cytokines, regulatory 
mechanisms or promoter methylation. Regulatory mechanisms may be via the 
suggested pathway of the epithelial–mesenchymal-transition (EMT) as the 
process of acquisition of an invasive phenotype by tumors of epithelial origin 
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can be regarded as a pathological version EMT (Martin et al. 2005) In, fact TJ 
determine epithelial cell polarity and disappear during EMT. 
The main functions ascribed to the TJ is to seal the intercellular space and to 
ensure the separation of apical and basolateral fluid compartments of epithelia 
and endothelia. In this way they help to define apical and basolateral 
membrane domains of these polarized epithelial and endothelial cells. In 
addition TJ molecules act as intermediates and transducers in cell signalling, 
thus playing a role in the processes of cell differentiation, cell growth and 
proliferation. They act as cell–cell adhesion molecules and function as a barrier 
to cell migration. Successful assembly and maintenance of the TJ is 
accomplished by anchorage of the transmembrane proteins by the peripheral or 
plaque proteins such as ZO-1 which act as a scaffold to bind the raft of TJ 
molecules together and provide the link to the actin cytoskeleton and the 
signalling mechanism of the cell 
It is becoming increasingly clear that the development of human cancer is 
frequently associated with the failure of epithelial cells to form TJ and to 
establish correct apicobasal polarity (I.J. Latorre et al.2005). An increasing 
number of studies have shown that numerous TJ components are directly or 
indirectly involved in cancer progression including ZO-1, ZO-2, claudin-7, 
claudin-1 and occludin. Highly differentiated adenocarcinomas provide an 
important insight regarding the use of TJ molecules as possible prognostic 
indicators and future targets for therapy. For example, in colorectal cancer it 
has been demonstrated that low expression levels of claudin-1 and ZO-1 were 
directly associated  with higher tumor grade (Tracey A. Martin et al. 2009). 
 
1.8 Adherens junctions 
 
   Adherens junctions (AJ) perform multiple functions 
including adhesion of the cell membrane to adjacent cells, anchoring of the 
cytoskeleton to the plasma membrane, cytoskeletal remodeling, regulation of 
the local stability of membrane and intracellular trafficking and transcriptional 
regulation. They are responsible for the formation and maintenance of tissues 
and organs in multicellular organisms. The core of the AJ includes interactions 
among transmembrane glycoproteins of the classical cadherin superfamily, 
such as E-cadherin and N cadherin, and the catenin family members including 
p120-catenin, β-catenin, and α-catenin. Together, these proteins control the 
formation, maintenance and function of AJ. Classical cadherins are Ca2+-
dependent adhesion proteins and have five characteristic extracellular cadherin 
(EC) repeat domains, that represent critical components of many intercellular 
junctions. These domains form trans-cadherin interactions between 
neighboring cells and initiate weak cell-cell adhesion and formation of the AJ  







Figure10:N- cadherin in adherens junctions. The cadherin superfamily are characterized by an 
extracellular domain with multiple, highly five cadherin repeats that represent Ca2+-binding sites, critical 
components of many intercellular junctions(from Gerhard Christofori 2006) 
 
The binding of Ca2+ to each EC domain is required for the correct 
conformational organization of the cadherin extracellular domain (Pokutta S, et 
al. 1994) and this association undergoes homophilic interaction with that of 
cadherins present on the apposed cells. In fact, the interaction of calcium ions 
with these sequences controls the conformation of the extracellular domain 
(Pokutta et al. 1994), switching its adhesive function “off” and “on. 
AJ are important during development, playing a central role in cell sorting and 
compartmentalization (Brasch J et al. 2012), and they are also ubiquitously 
expressed throughout the adult human body. During normal development and 
in pathological contexts (such as cancer), opportunistic cell–cell contacts either 
are self-reinforcing, leading to the formation of stable intercellular junctions, or 
induce cell-contact instability, leading to cell–cell intercalation or even cell 
migration. Despite their importance, the mechanisms leading to these opposite 
cell responses are only partially understood. 
E cadherin is the main cadherin which induces the formation of stable 
intercellular adherens type junctions in epithelial cells (Gumbiner et al. 1988; 
Me`geet al. 1988). However, N-cadherin, which is mostly expressed in neural, 
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endothelial, cardiac and skeletal muscle cells, in colorectal adenocaricinoma 
(RKO cells), triggers a wide range of cell responses, as well. The molecular 
and cellular mechanisms leading to this variety of cell responses are not 
currently known, but they might involve differential recycling (Kawauchi et al. 
2010), anchoring of cadherins to actin networks (Giannone et al. 2009), co-
activation of growth factor receptors (Hazan et al. 2004) or other signaling 
pathways (Ratheesh et al. 2012) that regulate the stability of adhesion 








































2. AIM OF STUDY 
 
   Hypomorphic mutations of the human DKC1 gene cause 
a congenital disease (X-DC), pointing out that the gene is involved in essential 
functions.  
DKC1 is in fact highly conserved and implicated in a wide and disparate 
spectrum of basic and essential cellular processes, such as ribosome biogenesis, 
pseudouridylation of cellular RNAs,regulation of IRES-dependent 
translation,nucleo-cytoplasmic shuttling, DNA repair, stem cell maintenance, 
telomere integrity and snoRNA-derived miRNAs production. While the list of 
possible gene functions progressively increased, the underlying mechanisms 
remained to be fully elucidated.  
To characterize in more detail the effects triggered by DKC1 loss of function, I 
focussed my research activity on the generation of a stable cellular model, not 
yet available, that could allow to reduce gene expression upon inducible RNA 
interference (RNAi). In addition to be stable and reproducible, the system was 
also aimed at silencing the most abundant dyskerin isoform without affecting 
the expression of the alternatively spliced isofom 3, which is characterized by 
retention of intron 12 and by a cytoplasmic localization.  Once setted-up the 
system, I finalize subsequent experiments to characterize the main effects 
triggered by dyskerin depletion. One of the main challenge to understanding 
the molecular basis of the X-DC is that of establishing if the disease must be 
considered mainly a telomerase disorder, or telomere deficiency is just one of 
the consequences of perturbed H/ACA snoRNP functions. I thus focussed my 
analyses on the effects triggered by dyskerin depletion well before telomere 
erosion, in order to define the spectrum of telomere-independent outcomes. 
Intriguingly, I found that one of the main outcome was that of affecting cell 
adhesion. This finding pushed me to concentrate subsequent experiments on 
the role played by this protein at the plasma membrane, so I defined its 
interactions with component of focal adhesions and of tight and adherens 
junctions. The results obtained revealed a novel and unexpected biological 















3  MATHERIALS AND METHODS 
 
3.1 Design and cloning of short hairpin RNAs. 
 
 shRNAsequences were ordered as oligos (Sigma) and 
cloned into pLKO-Tet-On (Novagen). The oligos were: Oligo Forward 5’ 
CCGGTATGTTGACTACAGTGAGTCTCTCGAGAGACTCACTGTAGTC
AACATATTTTT3’Oligo Reverse 5’ 
AATTAAAAATATGTTGACTACAGTGAGTCTCTCGAGAGACTCACTG
TAGTCAACATA 3’ Oligos were annealed and ligated in pLKO-Tet-On 
digested with AgeI and EcoRI enzymes (promega). Then competent Stbl4 E. 
coli cells (Invitrogen) were transformed with ligation reaction products. 
Plasmidic DNA from some positive clones was sequenced to confirm the 
identity of shRNA construct. 
3.2 Cell culture, transfection, and selection.  
 
 To generate a stable cell line, transfections of RKO cells 
were performed using 3µg pLKO-Tet-On-shDKC1 and 12 µl of Metafectene 
Pro (Biontex), following manufacturer's instructions. Following a 20-day 
puromycin selection (750 ng/ml, Sigma) some clones were collected and 
grown in DMEM (Dulbecco’s Modified Eagles Medium) supplemented with 
FBS 10% (Clontech, tetracycline free) 2 mM L-glutamine, penicillin 100 U/ml, 
streptomycin 100 µg/ml and 0,75µg/mlpuromycin at 37°C 5% CO2 in a 
humidified chamber. 
 
3.3 Growth curve of doxycycline treated and untreated cells.   
 To measure cell growth, equal number of dox- and dox+ 
cells (105/dish) were seeded in triplicates in 35mm plates and incubated for 
various periods of time. Cells were harvested every 24 h up to 4 days and 
counted by the Trypan blue dye exclusion method. 
 
3.4 Cell proliferation rate assay using MTT.  
 
 RKO cells dox+ and dox- were seeded in triplicate at the 
density of 5×103 cells/well in 96-well plates. The day after, cell culture 
medium was aspirated and, after a washing in PBS, replaced with 100 μL of 
0.5 mg/ml MTT solution per well. After 4h of incubation at 37°C in a 5% CO2 
incubator, the medium was removed and the precipitated formazan was 
dissolved in 100 μl of acidic isopropanol. The absorbance was quantified by 





3.5 FACS analysis  
 
   Control and doxycycline treated cells at the indicated 
time were trypsinized, counted, washed three time in phosphate-buffered saline 
(PBS) and fixed in ice-cold methanol at -20 °C overnight. Cells were then 
washed twice with cold PBS, counted and rehydrated at density of 106 cells/ml 
by incubation in PBS for 30 min on ice. Subsequently, cells were resuspended 
in  hypotonic solution 0.1% Na-Citrate, 50 μg/mL RNAse, 50 microg/ml 
propidium iodide and incubated for 30 min in the dark at R.T. The DNA 
content of the labeled cells was measured using a Becton Dickinson FACS 
Calibur flow cytometer and data were analyzed using the Cell Quest Pro and 
ModFit 3.0 softwares. 
 
3.6 Protein extraction and quantification  
 
   For protein extraction, cells were washed twice with ice 
cold PBS, detached from dish by a cell scraper and harvested in 4 ml of PBS. 
Cells then were pelleted by centrifugation for 5 minutes 1400xg at 4°C. The 
PBS was eliminated and cells resuspended by gentle vortex in 100 µl of RIPA 
lysis buffer. After 30 minutes of incubation in ice, the cell lysates were 
transferred in micro centrifuge tubes and centrifuged for 15 minutes 14000 rpm 
at 4°C to eliminate insoluble material. The supernatants were transferred in 
new tubes and stored at -80°C. Protein concentration of extracts was 
determined by the BioRad reagent following manufacturer’s instructions. 
 
3.7 Western blot analysis 
 
   Samples were run on a SDS-PAGE under reducing 
conditions, transferred onto 0.2 mm nitrocellulose filters (Ge Healthcare), and 
blocked with 5% dried milk protein in TBST buffer. Then membranes were 
incubated with anti-dyskerin (sc-48794), anti-paxillin (sc-365379), anti-
GAPDH (TA 30884), anti-profilin (sc-137236), anti-P21 (TA307018), anti-
procaspase 3 (sc-7148), anti-caspase 3(04-439), anti- β-tubulin (E7-s) anti-
PARP 1 (sc-7150) anti- integrin β1 (MAB1965) anti-FAK (MA-5644), anti α-
actinin (sc-166524) anti-vinculin (ab18058) anti-dyskerin N-terminal 
(SAB2104539) for 2 hours at RT. The membranes were washed twice for 5 
minutes with TBS-t-; then they were exposed to anti-rabbit or anti-mouse 
(Bethyl) in TBS-t-m for 1 hour. Membranes were washed again in same 
conditions and exposed to ECL-Plus (Advasta) for 1 minute. The excess of 
ECL-Plus was eliminated and chemioluminescence was visualized exposing 






3.8  Quantitative Real-Time Reverse Transcription Polymerase Chain 
Reaction  (qRT-PCR). 
 
   The protocol employed for total RNA extraction and the 
preparation of first strand cDNA were as previously described (Turano et al. 
2008) qRT-PCR experiments were performed using the iQ5 Multicolor Real-
Time PCR Detection System (Bio-Rad) under the following conditions: an 
initial denaturation step of 95 °C for 10 min, followed by 40 two-step cycles at 
95 °C for 10 s and at 60 °C for 60 s. Each 15-µl PCR reaction was conducted 
in triplicate using 5 ng of cDNA, 6 pmol of each primer and the iTaq Universal 
SYBR Green Supermix(Bio-Rad). The comparative CT method was used to 
calculate the  gene expression levels  relative to the GSH housekeeping gene. 
PCR oligo primers were selected using Primer3 software (http://frodo.wi.mit. 
edu/primer3/) and  their sequences, were designed on two different exons, in 
order to avoid amplification of genomic DNA contamination. 
 
DKC1 CTCGGAAGTGGGGTTTAGGT ACCACTTCAGCAACCACCTC 
GSH GGACTGGCCCTGGGAATT CCTTCTCTTGAGCAATCAGTA 
  
 
3.9  Scratch Wound Assay 
 
   RKO cells dox+ and dox- were cultured as triplicate in 
35 mm plates until reaching confluence. The cells were wounded with a 200 μl 
sterile pipette tip. To eliminate detached cells, culture medium was removed 
and wells were washed with PBS. Dox+ and dox- cells were putted on a time 
lapse support and scratch area was monitored over 24h using live-cell imaging 
system (Leica). 
3.10 Transwell migration assay  
 
   We assayed the migration ability of RKO cells using 24-
well Millipore transwell chambers with 8 μm membranes (Corning, USA). 
2x105 cells were seeded into the upper insert of each chamber in a serum-free 
medium and 10% FBS culture medium was added to the bottom chambers. 
After 24 hours of incubation, cells were washed with PBS three times and fixed 
with 4% paraformaldehyde. Non-migrated cells remained on the upper side of 
the filter were scraped off with a cotton swab. Cells attached to the bottom side 
of the membranes were stained with 0.5% crystal violet for 20 min, 
photographed and counted. 
 
3.11 Adhesion Assay. 
 
   Control and doxycycline treated cells were detached 
using PBS containing1 mM EDTA and were resuspended in a DMEM 
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adhesion medium containing 0.5% BSA. They were next plated to 30 min  in 
triplicates (2.0•105 cells/well) onto matrigel -coated wells, previously blocked 
for 60 min with 1% BSA/DMEM. Cells were allowed to attach  without 
spreading (6–7 min). The adhesion medium was discarded, and the attached 
cells were quantify by MTT assay.                                                                                               
 
3.12 Immunofluorescence Assay  
 
   RKO transfected cells were seeded on glass coverslips in 
6-well plates and treated for 48 and 72 h with doxycycline. The cells were 
fixed with 3,7% paraformaldehyde for 10 minutes, permeabilized in 0.5% 
Triton X-100 for 15 minutes and blocked in phosphate-buffered saline buffer 
(PBS) supplemented with 3% bovine serum albumin (BSA) for 30 minutes. 
After each step, the cells were rinsed in PBS. The cells were then incubated at 
RT for 1 h with antibodies anti-dyskerin (sc-48794), anti-paxillin (sc-365379), 
anti-integrin β1(MAB1965) anti-FAK (MA-5644), anti α-actinin (sc-166524), 
anti-pFAK Y397 (SC-81493), anti-N-caderin (4061S), anti-Zo1(5406S), anti-
vimentin (NCL-L-VIM-V9) followed by incubation with Cy3-conjugated goat 
anti-mouse IgG (Bethyl) or FITC-conjugated sheep anti-rabbit IgG secondary 
antibodies for 30 minutes at RT. Finally, the coverslips were mounted with 
Hoechst solutions on glass slides and examined under a fluorescence 
microscope (Nikon Eclipse E1000) and/or under a confocal microscope (Leica 
TCS SP5) with the same exposure settings. 
3.13 Wheat Germ Agglutinin (WGA) and phalloidin staining 
   To phalloidin staining, cells  were fixed with 3,7% 
paraformaldehyde for 10 minutes, permeabilized in 0.5% Triton X-100 for 15 
minutes and blocked in phosphate-buffered saline buffer (PBS) supplemented 
with 3% bovine serum albumin (BSA) for 30 minutes. After each step, the cells 
were rinsed in PBS. The cells were then incubated at RT for 30 min with 
(phalloidin DyLight 550 21835).Finally, the coverslips were mounted with 
Hoechst solutions on glass slides and examined under a confocal microscope 
(Leica TCS SP5) with the same exposure settings.                                                
To WGA staining, cells were incubated at RT for 10 min with (wheat germ 
agglutinin, texas red- conjugate W21405), fixed with 3,7% paraformaldehyde 
for 10 minutes. Finally, the coverslips were mounted with Hoechst solutions on 
glass slides and examined under a fluorescence microscope. 
 
3.14 Z-stack analysis 
 
   All captured pictures (in RAW format) have been 
analyzed and processed with ImageJ v1.440 software Z-stack analysis was 




3.15 Coimmunoprecipitation assay 
 
   1mg of protein extract was incubated overnight at 4°C 
with 5 μg of anti-pFAKY397 (SC-81493), anti-dyskerin (sc-48794), anti α-
actinin (sc-166524), anti-FAK (MA-5644), antibody preferably under gentle 
agitation or rotation, before addition of protein G-Sepharose (SIGMA) for 3 h. 
Beads were washed, resuspended in 40μl of loading buffer, and boiled for 10 










































4.1 Generation and characterization of stable shDKC1-inducible cell lines 
 
   My PhD project has been focussed on the generation of a 
stable cellular model, not yet available, in which it could be possible to reduce 
inducibly the expression of the DKC1 gene, miming the pathological 
conditions of X-DC patients. For this reason, I cloned in the PLKO-Tet On 
plasmid a sequence for a short hairpin RNA directed against DKC1 Isoform 1 
mRNA. This vector contains all the necessary components for the inducible 
expression of shRNA in target cells: a puromycin-resistant gene to permit the 
selection of transfected clones; sequences encoding the tetracycline repressor 
protein (TetR) downstream of the constitutive polymerase II hPGK promoter; 
the sequence encoding a shRNA targeted to DKC1. In the absence of 
tetracycline or its synthetic derivative doxycycline, shRNA expression is 
repressed by constitutively-expressed TetR protein bound at the Tet-responsive 
element within the H1 promoter. Upon the addition of tetracycline/ 
doxycycline to the growth media, shRNA expression is triggered and results in 
target gene silencing (Wiederschain et al. 2009). After have tested the silencing 
efficiency of the vector in transient transfection, the RKO colon rectal 
carcinoma cell line was used for obtain stably transfected clones. This cell line 
was chosen mainly because patients often develop tumors of the colon and 
rectum. Following a 20-day of puromycin selection (750 ng/ml, Sigma), 
independent clones were collected and maintained in media supplemented with 
tetracycline-free FBS (Clontech) and puromycin. Then cells were stimulated 
for 24h with different doxycycline concentration and the optimal doxycycline 
dose of stimulation was determined, by western blot analyses, to be of 
400ng/ml. In most experiments, stable inducible RKO clones were cultured in 
the absence or presence of doxycycline for 96 hours; in some cases, the 
induction was maintained up to two weeks. Dyskerin silencing was evaluated 
at both mRNA and protein levels. As shown in Figure 11, the mRNA level, as 
assayed by quantitative real-time PCR was significantly reduced starting from 
24 hrs of induction. Dyskerin protein levels were then evaluated by either 
immunofluorescence and western blot assays (11 B and C), and a decrease in 
dyskerin expression of about 50% was observed already after 24h of treatment. 
Confocal microscopy analyses of RKO cells (control and doxycycline treated) 
showed disappearance of dyskerin nucleolar accumulation upon antibiotic 










   Figure 11:Efficiency of the inducible DKC1 silencing system. (A) Real time RT-PCR assay shows a 
reduction of DKC1 mRNA accumulation following doxycycline administration.(B) Western blot and 
immunofluorescence analyses (C) confirm a decrease of dyskerin level and its progressive loss from 
nucleoli. 
 
As previously mentioned in the background section, our research group 
examined in detail the DKC1 transcriptional activity, with the aim to establish 
whether alternatively spliced isoforms could contribute to its functional 
complexity. In addition of a truncated isoform (isoform 3; Angrisani et al. 
2010) we found that an additional alternative transcript,named isoform 6, was 
efficiently exported into the cytoplasm (Turano et al. 2013). I thus 
checked the specificity of the silencing system by determining the expression 
levels of these alternative isoforms by western blots. In these experiments I 
used an antibody that recognizes an N-terminal dyskerin epitope, and thus is 
able to identify dyskerin isoforms 1, 3 and 6. As shown in Fig.12, the shRNA 
silencing RNA (targeted on  exons 12-13junction), cannot silence isoform 3; in 




Figure 12: Expression of dyskerin 
alternative isoforms upon silencing. As 
expected, isoforms 1 and 6 are significantly 
reduced after Dox-induced silencing; in 
contrast, expression of isoform 3 is unaffected. 





Once validated the silencing system, I checked whether the nucleolar 
localization of some components of H/ACA and C/D complexes (such as 
NOP10, fibrillarin), and that of nucleophosmin, a nucleolar phoshoprotein 
involved in the ribosome biogenesis, was perturbed upon DKC1 silencing. As 
shown in Fig. 13, no significant differences in the localization of the tested 
proteins was observed between control and doxycycline treated cells, leading 




Figure 13:Immunolocalization of NOP 10, fibrillarin and nucleophosmin in control and DKC1 
silenced cells. No significant variation is observed between doxycycline-treated and untreated cells. 
 
 
4.2 Dyskerin depletion alters cell proliferation and cell cycle progression  
 
   I thus checked whether gene silencing perturbed cell 
proliferation, an effect already described upon shRNA transient transfection of 
prostate cancer cell lines 22Rv1 and Du145 (Sieron et al. 2009) and human 
osteosarcoma (U2OS) and cervical carcinoma (HeLa) cell lines (Alawi and Lin 
2011). I followed cell proliferation by both direct counting of viable cells or by 
measuring the mitochondrial metabolic rate using MTT[3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide], that indirectly reflects 
viable cell number. Proliferation of doxycycline-treated cells progressively  
decreased upon time, with the highest level of growth inhibition observed at 96 








Figure 14:Cell proliferation following doxycycline treatment. Growths curves (A) and MTT assays 
(B) showthat a decrease of cell proliferation occurs after various time of silencing induction. 
 
Since in literature is reported that U2OS dyskerin-depleted cells and mouse 
embryonic fibroblasts characterized by the expression of catalytically inactive 
dyskerin undergo cell cycle arrest at G2-M phase (Alawi and Ping Lin. 2011; 
Gu et al. 2013), I checked by FACS analysis if the RKO silenced cells were 
similarly subjected to a G2-M block. As evidenced in Fig.15, I instead found 
that RKO doxycycline-treated cells show a significant increase in the G1 
percentage (42.4% compared to 33, 5% of control cells) after 72h of treatment. 
This increase is accompanied by a slight reduction in the S-phase percentage 
(42.8% compared to 46.9% of the control cells) and a consequent reduction in 




Figure 15: F.A.C.S analysis of control and DKC1silenced cells. Dyskerin depleted cells (on the right) 





To further check this aspect, I tested by Western blotting analysis the 
expression level of p21, a protein that plays a key role in G1/S cell cycle arrest 
(Rowland and Peeper. 2006; Abbas and Dutta. 2009). p21 binds cyclin E-
CDK2, preventing proliferation of DNA-damaged cells and causing a 
delay/arrest in the G1 phase (Kang et al.2005). In keeping with FACS results, 




Since cells can enter in an irreversible growth-arrested stage called replicative 
senescence (Campisi, 2005), I perfomed a β-galactosidase staining, an assay 
routinely used to detect senescent and aging cells (data not shown) to evaluate 
this possibility. Cells after 96h of silencing were then stained by β-
galactosidase. The results obtained (not shown) ruled out the possibility that 
senescence induction is a precocious effect of gene silencing.  
 
4.3 Dyskerin depletion does not induce apoptosis  
 
   I then wondered whether the observed decrease in cell 
proliferation could be due to the onset of apoptosis or necrosis processes. 
These aspects were first followed by acridine orange and ethidium bromide 
(AO-EB) staining, in order to reveal nuclear changes and apoptotic bodies 
formation (Ribble et al. 2005). Acridine orange (AO) is a vital dye that  
penetrates both living and death cells and stains specifically nucleic acids 
(DNA/RNA). Once bound, its fluorescence has a maximum emission at 525 
nm (green emission). In contrast, Ethidium Bromide (EB) penetrates only in 
cells with damaged membrane. After AO-EB double staining, living cells are 
colored uniformly in green, while apoptotic or necrotic cells have incorporated 
EB and thus are colored in orange; in turn, orange apoptotic cells can be 
distinguished from those necrotic because of the presence of condensed 
chromatin (Attari et al.2009).This staining revealed that no significant increase 
in the number of apoptotic/necrotic and living cells. (Figs. 17A e 17B) 
occurred  immediately upon DKC1 silencing. 
 
Figure 16. p21 expression upon DKC1 
silencing. Western blot analysis 






In order to confirm this aspect, I checked by Western Blot analysis the 
expression of Poly ADP-ribose polymerase-1 (PARP-1) and Caspase 3 (Cas3), 
two proteins routinely used as apoptotic markers. PARP-1 is a nuclear protein 
essential for cell function and survival (Cotter TG. 2009; Bhaskara VK et al. 
2009) that in apoptotic cells is processed by caspases 7 and 3. This cut results 
in PARP-1 inactivation and in the completion of the apoptotic process. As 
showed in Fig.18, no PARP-1 fragment was observed in the silenced cells after 
72 hrs of silencing. Similarly, I dind’t observed any activation of pro-Caspase 3 
(Fig.18), and the same results were obtained after 10 days of Dox induction 
(not shown). In contrast, in cells induced to apoptosis by puromycin treatment 
(used as positive control) both PARP-1 and pro-Caspase 3 were efficiently 
cleaved (Fig. 18). Taken together, these data indicated that the decrease in cell 





Figure 17: Acridine orange and ethidium 
bromide staining of DKC1 silenced cells. 
A:After staining of Dox-treated and 
untreated cells, green and orange cells were 
counted .                      
 B: Statistical analysis indicates that no 
significant difference in the percentage of 
apoptotic/necrotic and living cells occurs 
between control and silenced cells. 
Figure 18: Western blot analysis of apoptotic markers in dyskerin-depleted cells. Cleavage of either 
PARP-1 and Pro-Cas3 was not observed after 72 hrs of Dox-induction; in contrast, in puromycin-treated 
apoptotic cells (Ctrl+) PARP-1 and ProCaspase 3 were efficiently cleaved.  
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4.4 Dyskerin depletion perturbs cell morphology and adhesion.  
 
   Following doxycycline treatment, I noticed that some 
silenced cells start losing their shape, becoming round and detaching from the 
surface, while control cells  maintained  an epithelial-like, non refractile 
morphology (Fig.19). To exclude that this effect could depend on doxycycline 
administration, untransfected RKO cells were treated with increasing 
doxycycline doses; however, no changes in morphology or cell adhesion was  
noticed, indicating that the observed effect were strictly related to DKC1 
silencing. Since about 15% of the silenced cells detached from the plate, I 
collected and stained these cells with trypan blue, used to stain selectively dead 
tissues or cells, to further exclude the possibility that their detachment was due 
to cell death. However, these cells proved to be fully viable and, when seeded 
in Dox- culture medium, rescued normal growth and morphological properties.  
 
  
Figure19: DKC1silencing induceschanges in cell morphology. Following doxycycline treatment, some 
DKC1 silenced cells cells assume a round-shape morphology (see red arrows). 
I then stained silenced and control cells with the antibody against Wheat Germ 
Agglutinin (WGA), a carbohydrate-binding protein that selectively recognizes 
the predominant sugar residues found on membranes, and with Phalloidin, a 
dye that binds F-actin, in order to get a preliminary view on cell structure.                                  
As shown in Fig. 20, WGA perfectly delineated the cell boundaries and  
highlighted the round shape of dyskerin-silenced cells, most of which  
remained isolated, unlike control cells that adhered each other like in a 
monolayer. Phalloidin staining suggested that reduced actin polymerization 
took place within the restricted cytoplasmic areas of the silenced cells, 
implying the occurrence of cytosketal rearrangements. Since the overall picture 
suggested a possible role of dyskerin incell adhesion, I focused subsequent 







4.5 Dyskerin depletion alters cell-substrate adhesion 
 
   To check the cell-substrate adhesion properties of DKC1 
silenced cells, an adhesion assay was performed. Silenced and control cells 
were seeded in plates coated with matrigel (a mixture of laminin, collagen IV 
and proteoglycan that mimics the basement membrane) or in plates coated with 
BSA, used as control. After 30 min of incubation, adherent cells were 
quantified by MTT assay. As shown in Fig.21, the results show that the 




Adhesion of cells to the extracellular matrix (ECM) is a key parameter able to 
regulate cell morphology, migration, proliferation, survival and differentiation 
Figure 21: Cell-substrate adhesion 
assay. In the assay, control and 
silenced cells were quantified by 
MTT. The histogram shows that 
DKC1 silenced cells exhibit reduced 




Figure 20: Phalloidin and 
WGA staining of control 
and dyskerin-depleted 
cells. Following DKC1 
silencing, cells acquire a 
round shape and exhibit a 




(Gumbiner et al. 1996).Adhesion to ECM is mediated mainly by integrins. 
Each integrin acts as receptor that recognizes a distinct ligand on the cell 
surface, while its cytoplasmic domain acts as a platform for the recruitment of 
scaffold and signaling proteins at the inner surface of the plasma membrane, 
where structures that mediates tight adhesion to the ECM, called Focal 
Adhesions (FA), are composed (Hynes, 2002).  
I thus analyzed the expression of integrin β1 monomer in the silenced cells. As 
shown in Fig.22, integrin β1 expression is reduced, particularly at cell baseline. 
Moreover, I noticed that the protein accumulates in the perinuclear region of 
dyskerin-depleted cells. This region might correspond to the  "PeriNuclear 
Recycling Compartment" (PNRC), where integrins, once internalized, can be 




Figure 22: Expression and basal-apical distribution of integrin β1 in control (A)  and silenced cells 
(B). 
     In keeping with this observation, western blot analysis confirmed that a slight 
reduction of integrin β1 expression level occurs upon dyskerin depletion (Fig. 
23).These results are compatible with a destabilization of Fas, that would 
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consequently reduce adhesion to ECM and possibly account for the presence of 








To gain further support to this view, I analyzed the expression of the focal 
adhesion tyrosine kinase (FAK). FAK acts as molecular switch, playing a 
central role in the signaling cascades mediated by integrins (Mitra and 
Schlaepfer, 2006).In effect, FAK total levels decreased significantly upon 









Confocal microscope analyses of cells after 48h of DKC1silencing confirmed 
the strong decrease of FAK expression (Fig.25). This reduction may affect 
normal localization of FAK at the  focal contact sites. 
 
Figure 23: Expression of integrin β1 
in the silenced cells. Western blot 
analyses indicates that integrin β1 
accumulation is slightly reduced upon 
DKC1 silencing. 
Figure 24: Expression of FAK in the 
silenced cells. Western blot analyses 
indicates that FAK accumulation is 
significantly reduced upon DKC1 
silencing. 
Figure 25: FAK immunofluorescence analysis. Confocal microscopy  analysis shows a decrease of 
FAK expression in dyskerin-depleted cells (B) respect to control cells (A) 
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Finally,I analyzed the expression of paxillin, an adaptorprotein that integrates 
adhesion and growth factor-related signals at the interface between membrane 
and the actin cytoskeleton (Digman et al. 2008).Silenced cells show a decrease 




Figure 26.Confocal  microscopy analysis of paxillin expression. Immunofluorescence analyses show a 
decrease of paxillin expression in dyskerin depleted cells (B) respect to control (A). 
 
As shown in Fig. 27, western blot analyses confirmed the reduction of paxillin 










4.6 Dyskerin interacts directly with FAs components 
 
   Finally, I asked whether dyskerin could interact directly 
with FAs components, stabilizing or recruiting them at FA sites. To check this 
hypothesis, I first perfomed co-immunoprecipitation experiments, analyzing 
the possible interaction of dyskerin with FAK, and more specifically with its 
tyrosine 397 posphorylated form. In this approach, I then used not only the 
previously mentioned antibody able to recognize all FAK isoforms, but also an 
Figure 27: Western blot analysis 
of paxillin expression in dyskerin 
depleted cells. Levels of both 
paxillin and its phosphorylated 
form are markedly reduced upon 
DKC1 silencing  
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antibody that specifically reacts with the tyrosine 397 posphorylated FAK 
isoform. Intriguingly, co-immunoprecipitation essays showed direct interaction 





Figure 28:Dyskerin- FAK direct interaction. Co-imunoprecipitation experiments reveal direct 
interaction between FAK and dyskerin (A), as well as of Y397 p-FAK and dyskerin (B). 
 
Since auto phosphorylation of FAK at residue Tyr-397 occurs upon integrin 
clustering at the plasma membrane, (Ben-Zion Katz et al. 2003) this result 
suggested a new and so far unpredicted intracellular localization of dyskerin. 
Since the dyskerin isoform 1 has been so far considered to be localized 
exclusively into the nuclei, I wished to further investigate FAK-dyskerin 



























Figure 29: Co-localization between FAK(A), p-FAK and dyskerin (B).Cofocal analysis show that 





















Figure 30:Co-localization of dyskerin and FAK. Detailed view images acquired at different 
focal planes conferming  that the co-localization of dyskerin and FAK(yellow arows )occurs 









Indeed, this analysis confirmed that dyskerin colocalizes with FAK and its 
specific phosphorylated form on Y397 at cell plasma membrane, at the FAs 
level.                                                                                                                
I also performed co-immunoprecipitation and co-localization experiments in 
order to check dyskerin/α-actinin potential interaction.Also in this case, both  
approaches indicate the occurrence of a direct interaction between the two 
proteins (Fig.32). 
 
Figure 31:Co-localization of dyskerin and pFAK. Detailed view images acquired at different 





























Figure 32:Co-localization and co-
immunoprecipitation of dyskerin 
and α-actinin. Both approaches 
indicate the occurrence of a direct 









Conversely, I was unable to evidentiate any interaction between dyskerin and 
paxillin(data not shown).  
 
4.7 Dyskerin depletion perturbs cell-cell adhesion. 
 
   I subsequently focussed on the effects of dyskerin 
depletion in cell-cell adhesion. RKO cells, although of epithelial origin, 
express N-cadherin (a marker typically expressed in neural, endothelial, 
cardiac and skeletal muscle cells) instead of E-cadherin in their adherens 
junctions (Buck et al. 2007). I thus analyzed the expression of N-cadherin and 
of ZO1, a protein involved in the formation of thetight junctions of polarized 
epithelia. Immunofluorescence analysis showed a decrease of N-cadherin at 
adherens junctions of the silenced cells (Fig. 34); moreover, the protein showed 
a vesicular-like pattern. The expression of ZO-1,a protein localized at apical 
cell-cell contact regions (Tsukita et al 1999) similarly decreased upon gene 
Figure 33: Co-localization of dyskerin and α-actinin .A detailed view of images acquired at 
different focal planes conferming co-localization of dyskerin and α- actinin at different planes 
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silencing. However, ZO1 levels fluctuate among the silenced cells, with some 
of them remaining completely unstained; moreover, the protein often does not 




Figure 34:  Confocal microscopy analysis of N-cadherin expression in dyskerin-depleted cells. Note 




Figure 35: Immunoflorescence analysis of ZO1in dyskerin depleted cells.  Note that ZO1 expression 
is irregularly reduced and it is often absent from cell boundaries.  
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Finally, I analyzed the expression of α-actinin, a major component involved in 
microfilament stabilization and in the link of microfilaments to adherens 
junction (AJs) and FAs components (reviewed by OteyandCarpen. 2004; 
Sjoblom et al. 2008).Four isoforms of α -actinin are expressed in a tissue-
specific manner in human cells. Actinin-2 and -3 are specifically expressed in 
muscle cells, whereas actinin-1 and -4 are ubiquitously expressed (Beggs et al. 
1992; Millake et al. 1989; Youssoufian et al. 1990). Although α-actinin1 and 4 
are approximately 84% identical and share 90% similarity in their amino acid 
sequences,only the isoform 4 is reported to have a nuclear localization (Khotin 
MG et al.2009; Zhao et al. 2015). 
After 48h of DKC1 gene silencing, I observed by immunofluorescence a neat 
decrease of α-actinin level at the adherens junctions and an increase of its 
diffuse localization in the nuclei. In keeping with these results, western blot for 
analysis  of nucleus/cytoplasm fraction confirmed this observation (Fig 36). 
Since the antibody used in my experiments recognizes both actinin-1/-4 
isoforms, its likely that it followed the nuclear accumulation of actinin-4, as 













Because of the important role played by actin-binding proteins in the 
stabilitation of AJs and FAs, I also checked the expression of other actin-
binding proteins, such as vinculin, a cytoskeletal protein involved in anchoring 
F-actin to the membrane (Gingras A et al. 2006) and profilin, a protein 
involved in the dynamic turnover and restructuring of the actin cytoskeleton 
(Bae YH at al. 2010). However, the expression level of these proteins remained 
unvaried following dyskerin depletion (Fig. 37). 
 
Figure 36.Analysis of α-actinin 
expression in DKC1 silenced cells. 
Both immunofluorescence (A) and 
western blot (B) analyses show a 
decrease of α-actinin localization at 











4.8 Dyskerin depletion promotes a cell migratory behaviour  
 
    A specific characteristic of epithelial cells is their 
propensity to grow as a layer of extensively communicating cells, which 
express, at cellular junctions sites, specific epithelial proteins such as cadherin, 
occludins, claudins, all involved in maintaining of the epithelial layers integrity 
(Baum and Georgiou, 2011; Dusek and Attardi. 2011; Turksen and Troy. 
2011). Epithelial cells are typically polarized, with a basal side attached to 
extracellular matrix, lateral sides attached to adjacent cells, and an apical side 
facing the lumen of a vessel. Maintenance of this apico-basal polarity is 
achieved by the tight junctions, which prevent diffusion of apical membrane 
proteins (Yeaman et al.1999).Detachment of epithelial cells from  their matrix 
triggers a cellular reprogramming that can result in Epithelia-Measenchimal 
Transition (EMT). The defining characteristics of EMT are: change of cell 
morphology, mainly due to loss of cell adhesion molecules;loss of epithelial-
specific genes and gain of mesenchymal-specific genes; enhanced migratory 
capacity of cells (Matise et al. 2012).  Since dyskerin depletion induces 
changes in cell morphology and causes a reductionof cell adhesion, I wished to 
check also the migratory properties of the silenced cells, I thus performed a 
migration assay based on the use of a Boyden chamber. This assay consists of a 
cylindrical cell culture insert, with a defined pore size, nested inside the well of 
a cell culture plate. Cells are seeded in the top of the insert in serum-free 
media, while serum is placed in the well below. Migratory cells, that move 
through the pores toward the chemoattractant below, are then stained and 
counted. I observed a greater number of cells that cross the insert in the 
silenced sample compared to control cells, suggesting an increase of cell 
migration(Fig. 38). 
Figure 37. Expression analysis of profilin and vinculin in dyskerin-depleted cells. Western blot 
assays did not show any  significant variation in the level  of profilin and vinculin accumulation 





To confirm the increase in cell  migration, I also performed a scratch assay in 
time lapse, which allowed us to evaluate the cell ability to heal a cut made 
inside a confluent plate. Migration was followed for 24 hours, i.e. the 
replication time of RKO cells, to minimize any influence due to variability in 
cell proliferation. I observed that in the selected time control cells don’t cross 
the cut, while advance at both sides evenly. Instead, the silenced cells cross the 




Figure 39: Scratch assay in time lapse. Doxycycline- treated cells cross the cut more rapidly, suggesting 
an enhanced migratory behavior. 
 
To further investigate the possibility that depletion of human dyskerin could 
promote EMT, as recently shown in Drosophila (Vicidomini et al. 2015) I 
preliminarily analyzed the expression of vimentin, a protein that composes 
intermediate filaments and  represents the major cytoskeletal component of 
Figure 38: Boyden 
chamber assay. The 
migration assay shows an 
increase in cell migration of 
about 50% for the silenced 
cells. The experiment was 
performed in triplicate; 
deviation standard of cell 




mesenchymal cells.As shown in Fig. 40 ,an increase of this mesenchymal 
marker noticed in the silenced cells, supporting the view that dyskerin 
depletion may promote EMT. Worth noting, short filamentous structures 
termed “vimentin squiggles”are frequently visible in the silenced cells. While 
vimentin network extend to the cell pheriphery in non-motile cells, squiggles 
are short fibril that act as motile structures able to altering cell shape and 












Figure 40: Analysis of 
vimentin expression. 
Confocal microscopy 
analysis shows an 
increase of vimentin, a 
mesenchymal marker, in 
DKC1silenced cells. 
Note that in these cells 
vimentin is frequently 
organized in squiggles, 






5.  DISCUSSION 
 
   In humans, loss of functions  mutations in the DKC1 
gene cause the X-linked dyskeratosis congenita, an inherited multisystemic 
disorder characterized by mucocutaneous features, bone marrow failure, 
premature aging, loss of stemness and a puzzling predisposition to cancer 
(Kirwan at al. 2009). DKC1 encodes an evolutionarily conserved protein, 
called dyskerin, whose activity is essential for vitality (Heiss et al.1998). 
Dyskerin is a nucleolar protein with at least two main nuclear functions. First, 
the protein is a core component of H/ACA small nucleolar ribonucleoprotein 
particles (H/ACA snoRNPs) involved in rRNA processing (Kiss et al. 2006). 
Within H/ACA snoRNPs, dyskerin also acts as pseudouridine synthase, 
promoting the conversion of specific uridine residues to pseudo-uridines. In 
addition, dyskerin stabilizes the telomerase enzymatic complex through its 
binding to the H/ACA domain of the telomerase RNA component (hTERC) 
(Cohen et al. 2007). Moreover, dyskerin has been also involved in a variety of  
additional functions, such as internal ribosomal entry site (IRES)-dependent 
translation, DNA repair and stem cell renewal, even though the underlining 
mechanisms still remain to be fully understood and characterized.   
Data available on the effects of DKC1 gene silencing have so far been obtained 
by transient silencing. To get more detailed information, I instead planned to 
establish a cellular model able to stably silence DKC1 expression. The creation 
of a stable cell line provides many advantages over transient gene silencing, 
such as avoiding the need for repeated transfections, establishing a more 
uniform and reproducible gene silencing, and providing an approach to the 
study of long-term outcomes. The silencing system was established in the RKO 
cell line and it was engineered to avoid the silencing of the alternatively spliced 
dyskerin isofom 3, characterized by retention of the intron 12, and by a 
cytoplasmic localization. Once obtained and validated the system, I firstly 
tested whether cell proliferation was reduced in the silenced cells, as previously 
observed for other human cell lines upon DKC1 transient silencing (Sieron et 
al. 2009; Alawi and Lin 2010). Direct counting of viable cells and MTT assays 
confirmed that dyskerin-depleted cells show a decrease in cell proliferation 
.The reduced proliferative capacity typical of X-DC patients and of DKC1 
silenced cells is in striking contrast with the increase of tumour susceptibility, 
that in fact represents one of the most puzzling feature of the disease.  
In my experiments, the decrease of cell proliferation was due to a G1/S delay, 
in keeping with the data reported by Jiang et al. (1993) for yeast cells depleted 
for CBF5p, the dyskerin homologue protein. However, I noticed that Alawi and 
Ping Lin (2011) reported that dyskerin-depleted cells have a G2/M delay; the 
same result was obtained in mouse embryonic fibroblasts characterized by the 
expression of a catalytically inactive dyskerin by Gu et al. (2013).To further 
check this point, I thus followed the expression of p21, a protein that binds 
cyclin E-CDK2 and prevents the cell cycle progression (Rowland and Peeper. 
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2006; Abbas and Dutta 2009; Kumari et al.2014). Indeed, p21 expression 
increased in RKO cells upon DKC1 silencing, thus supporting the occurrence 
of a G1/S delay. 
I then checked whether the proliferative decline could be due to cell death. To 
this end, I stained the cells with acridine orange and ethidium bromide (AO/EB 
staining), and followed the activation of PARP-1 (poly ADP-ribose 
polymerase) and caspase 3. Both approaches lead to negative results, thus 
indicating that the observed decrease in cell number was not due to cell death. 
Indeed, the most marked effect observed in the RKO dyskerin-depleted cells 
was a morphological change of cell shape. Although previously noticed by two 
authors (Alawi and Lin. 2010;Sieron et al. 2009), this aspect still remained to 
be explained.  
As concerning RKO cells, I noticed that  upon DKC1 silencing they acquired a 
round shape, and a subset of them (about 10-20%) detached from the plate. 
Moreover, phalloidin staining evidenced a reduced degree of F-actin 
polymerization in the narrow cytoplasmic area of dyskerin silenced cells, 
suggesting the occurrence of a cytoskeletal rearrangement.  The detached cells 
are still stained by the trypan blue vital dye and, if replated in a culture medium 
without doxycycline, retain the ability to reattach and proliferate normally. 
These observations strongly suggested the possibility that dyskerin can 
promote cell adhesion, thus pushing me to perform cell-substrate adhesion 
assays. Intriguingly, these assays confirmed that silenced cells showed a lower 
adhesion to extracellular matrix components than control cells. 
Cells attach to a surface by mean of specialized structures called focal 
adhesions (FAs). These cell-matrix attachment sites play essential roles in 
many vital cellular processes, including proliferation, survival andmotility 
(Sastry and Burridge 2000). At FAs sites, clusters of transmembrane integrin 
receptors bind to matrix molecules and associate with a large protein complex 
consisting of a variety of anchor and signaling proteins bound to actin 
filaments. Because of the importance of integrins in the regulation of cell-
matrix adhesion process, I tested the expression level of integrin- β1,and found 
it was decreased at the surface of the dyskerin-depleted cells. Worth noting, in 
some silenced cells integrin-β1 accumulates irregularly at the "perinuclear 
recycling compartment" (PNRC), where the internalized integrins can be 
recycled by Rab 11 proteins. Following endocytosis, integrins travel in fact to 
early endosomes  to be either returned directly to the plasma membrane in a 
Rab4-dependent manner, or moved to the PNRC tobe recycled by a Rab11-
dependent mechanism (Sejeong Shin et al. 2011). However, although integrins 
are predominantly recycled back to the plasma membrane, during cell 
migration they are in part transferred to lysosomes for degradation. The 
irregular accumulation of integrin β1 in the PNRC thus suggests an altered 
vesicular trafficking. 
I then followed the expression levels oftwo other FAs components: paxillin, 
that links actin filaments to integrin at the cell adhesion sites, and the focal 
adhesion kinase FAK, that plays a central role in signaling cascades mediated 
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by integrins, (Mitra and Schlaepfer 2006). Intriguingly, the expression of both 
proteins, resulted reduced in the silenced cells. These findings are all 
compatible with a destabilization of FAs and a consequent reduction of 
adhesion to the ECM, and can thus account for the appearance of spherical, 
non-adherent cells.  
I then analyzed the expression of a subset of actin-binding proteins, such as 
profilin, vinculin and α-actinin. Among these proteins, only α-actinin 
underwent a variation in its expression upon DKC1 silencing. This protein 
represents a major component involved in microfilament stabilization and in 
linking microfilaments to adherens junctions and focal adhesion components 
(reviewed by Oteyand Carpen. 2004; Sjoblom et al. 2008). Noteworthy, I 
noticed that in the silenced cells α-actinin level decreases at the AJ, while 
increased in the nuclei. So far,only α-actinin 4 has been shown to havea nuclear 
localization; this protein has in fact been observed in the nuclei of several 
cancer cell lines upon actin depolymerization (Honda et al., 1998).Although α-
actinin nuclear functions are still unknown, recent studies reported a role in the 
NF-κB transcriptional activation, indicating that the protein is recruited at 
promoters of NF-κB target genes, such as IL-1β and IL-8(Zhao et al. 2015). In 
addition, a role of α-actinin 4 has been evoked in splicing and oxidative stress 
(Khotin MG et al.2009).  
Considering the bulk of above mentioned data, I wondered whether dyskerin 
could directly interact with some of the examined adhesion molecules. To this 
aim, I checked by co-immunoprecipitation experiments the possible interaction  
of dyskerin with FAK, Y397pFAK, α-actinin and paxillin. Intriguingly, FAK, 
Y397pFAK, α-actinin were actually found able to bind specifically dyskerin.  
Confocal microscopy analyses confirmed these interactions at the plasma 
membrane, unrevealing a so far undescribed dyskerin function.   
Considering that FAK molecules phosphorylated at residue Tyr-397 are located 
close to the plasma membrane (Ben-Zion Katz et al. 2003), it is possible to 
speculate that depletion of dyskerin could destabilize FAs, this way 
contributing to weakening cell-substrate adhesion. This hypothesis  is 
supported by the work of de Hoog. et al. (2004),who reported the assembly of 
transitory ribonucleoprotein complexes in the early stages of cell spreading at 
the so called “spreading initiation centers” (SICs). SICs are distinct from FAs, 
and their components include some RNA binding proteins, such as hnRNP K, 
hnRNP E1, and FUS/TLS, all functionally involved in controlling the rate of 
cell spreading. Since RNA is present, it seems possible that some of these 
mRNAsare locally translated into proteins, perhaps to fuel the assembly of 
FAs. As observed by de Hooget al. (2004) “SICs always seem to form directly 
above classical focal adhesions where they could be local protein factories 
producing the required components of focal adhesions”. Results reported here 
raise the intriguing possibilty that dyskerin can be a so far undetected SIC 
component. Worth noting, the interaction of dyskerin and α-actinin and their 
co-localization at cell apical membrane is further supported by the work of 
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Khotin et al. (2009) who identified by mass-spectrometry, dyskerin as a direct 
interactor of with α-actinin-4. 
Taken together, all results I obtained suggested that DKC1 silencing could 
promote a migratory cell behavior. During normal development and in 
pathological contexts (such as cancer), cell-cell contacts are modulated in order 
to be self-reinforced, in order  to establish stable intercellular junctions, or to 
be weakend, in order to allow cell-cell intercalation or migration. The 
development of human cancers is frequently associated with the failure of 
epithelial cells to form TJ and to establish apicobasal polarity (Latorre et 
al.2005). Moreover,a number of TJ components, including ZO-1,are directly or 
indirectly involved in cancer progression. For example, in colorectal cancer it 
has been demonstrated that reduced expression of ZO-1 is directly associated 
with higher tumor grade (Tracey A. Martin et al. 2009).The TJ loosening, as 
the  removal  of epithelial cells from  the matrix, can induce a cell 
reprogramming that allows cellular survival, a process known as epithelial–
mesenchymal-transition (EMT). This process involves morphological changes, 
loss of cell adhesion, loss of epithelium-specific markers, gain of mesenchymal 
specific  markers and  enhanced migratory  properties  of cells (Matise et al. 
2012).    
It is intriguing to note that  the bulk of data reprted here suggests  that dyskerin 
depletion induces many of EMT-specific features in human cells,  as recently 
noted in Drosophila (Vicidomini et al., 2015). The reduced expression of N-
cadherin, which ensures the formation of adherent junctions and of ZO1, that is 
involved in the tight junctions of polarized epithelia., adds further support to 



























   In order to better characterize the effects triggered by 
dyskerin depletion in human cells, I generated and validated a stable and 
inducible cellular system able to silence the DKC1 gene without affecting the 
expression of its alternatively spliced isofom 3, that is characterized by a 
cytoplasmic localization. This system proved to work efficiently and, 
compared to transient gene silencing, has the advantages of not requiring 
repeated transfections, triggering gene silencing more reproducibly, and 
allowing to check long-term effects. 
Once established the system, I firstly focussed my analyses on the effects 
exherted by dyskerin depletion well before telomere erosion, in order to define 
the spectrum of telomere-independent outcomes. Intriguingly, I found that 
dyskerin depletion perturbs cell-cell and cell-substrate adhesion, causing 
reduced expression of a subset of proteins involved in tight and adherens 
junctions and in focal adhesions. In parallel, the silenced cells change their 
morphology, acquiring a round shape. 
To shed more light on the role played by dyskerin in cell adhesion I then 
checked whether dyskerin could interact directly with focal adhesion 
components. Indeed,  co-immunoprecipitation and co-localization experiments 
converged to demonstrate that dyskerin is able to interact with FAK, Y397 
pFAK and α-actinin. These data point out that dyskerin plays  an unpredicted, 
non-canonical role of in cell adhesion, that was further supported by the results 
obtained by migration assays.  
These data add unforeseen information that can be of valuable help in 
understanding the puzzling relationship that links pseudouridine synthases loss-
























   I thank the prof Maria. Furia for constructive discussions 
and for her help in experimental planning. I also to thank the doctor Mimmo 
Turano for his essential contribution to this work, and the PhDs Alberto 
Angrisani and Rosario Vicidomi for their support and constructive comments. I 
am grateful to Valeria Costabile and Valentina Morra for the wonderful work 











































Abbas T, Dutta A.p21 in cancer: intricate networks and multiple activities. Nat 
Rev Cancer 2009; 6: 400-14. 
 
Alawi F and Lin P. Loss of dyskerin reduces the accumulation of a subset of 
H/ACA snoRNA-derived miRNA. Cell Cycle 2010; 9:. 2467-2469 
 
Alawi, F. and Lin, P. Dyskerin is required for tumor cell growth through 
mechanismsthat are independent of its role in telomerase and only partially 
related to its function in precursor rRNA processing. Mol. Carcinog. 2011; 50: 
334-45. 
 
Alawi, F. and Lin, P. Dyskerin localizes to the mitotic apparatus and is 
required for orderly mitosis in human cells. PLoS One 2013; 8:80805 
 
Alter, B.P., Giri, N., Savage, S.A., Rosenberg, P.S. Cancer in dyskeratosis 
congenita. Blood 2009; 113: 6549-6557. 
 
Angrisani Alberto, Rosario Vicidominia, Mimmo Turano and Maria 
FuriaHuman dyskerin: beyond telomeres BiolChem. 2014; 395(6):593-610 
 
Angrisani, A., Turano, M., Paparo, L., Di Mauro, C. and Furia, M. A new 
human dyskerin isoform with cytoplasmic localization. Biochim. Biophys. 
Acta 2011; 1810: 1361-1368. 
 
Arnez and Steitz Crystal structure of unmodified tRNA (Gln) complexed with 
glutaminyl-tRNA synthetase and ATP suggests a possible role for pseudo-
uridines in stabilization of RNA structure. Biochemistry 1994;  21;33: 
24:7560-7. 
 
Armanios M, Chen J-L, Chang Y-PC, Brodsky RA, Hawkins A, Griffin CA, 
Eshleman JR, Cohen AR, Chakravarti A, Hamosh A, Greider CW. 
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in 
autosomal dominant dyskeratosiscongenita. Proc Natl Acad Sci U S A. 2005; 
102(44):15960-4. 
 
Attari F, Sepehri H, Delphi L, Goliaei B. Apoptotic and necrotic effects of 





Bae YH, Ding Z, Das T, Wells A, Gertler F, Roy P "Profilin1 regulates 
PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing 
motility of MDA-MB-231 cells". Proc. Natl. Acad. Sci. U.S.A. 2010; 107 (50): 
21547–21552 
 
Ballarino, M., Morlando, M., Pagano, F., Fatica, A., Bozzoni, I. The 
cotranscriptional assembly of snoRNPs controls the biosynthesis of H/ACA 
snoRNAs in Saccharomy cescerevisiae. Mol. Cell Biol. 2005;.25: 5396-5403. 
 
Baum B1, Georgiou M.Dynamics of adherens junctions in epithelial 
establishment, maintenance, and remodelingJ Cell Biol. 2011;192(6):907-17.  
 
Beggs AH, Phillips HA, Kozman H, Mulley JC, Wilton SD, Kunkel LM, Laing 
NG..A (CA)n repeat polymorphism for the human skeletal muscle alpha-
actinin gene ACTN2 and its localization on the linkage map of chromosome 1. 
Genomics. 1992; 4:1314-5. 
 
Bellodi, C., Krasnykh, O., Haynes, N., Theodoropoulou, M., Peng, G., 
Montanaro, L.,Ruggero, D. Loss of function of the tumor suppressor DKC1 
perturbs p27translation control and contributes to pituitary tumorigenesis. 
Cancer Res. 2010; 70: 6026-6035. 
 
Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM,DePinho RA, et al. 
Telomere shortening and tumor formation bymouse cells lacking telomerase 
RNA. Cell 1997;91:25–34 
 
Bhaskara VK, Challa S, Panigrahi M, Babu PP. Differential PARP cleavage: 
an indication for existence of multiple forms of cell death in human gliomas. 
Neurol India. 2009;57 (3):264-8 
 
Blomster, H.A., Hietakangas, V., Wu, J., Kouvonen, P., Hautaniemi, S., 
Sistonen, L. Novel proteomics strategy brings insight into the prevalence of 
SUMO-2 target sites.Mol. Cell. Proteomics 2009;.8: 1382-1390 
 
Brasch J, Harrison OJ, Honig B, Shapiro L Thinking outside the cell: how 
cadherins drive adhesion. Trends Cell Biol 2012; 22: 299–310. 
 
Brault, M.E., Lauzon, C., Autexier, C. Dyskeratosiscongenita mutations in 
dyskerinSUMOylation consensus sites lead to impaired telomerase RNA 
accumulation and telomere defects. Hum Mol Genet. Hum Mol Genet. 2013; 
22(17):3498-507 
 
Buck E, Eyzaguirre A, Barr S, Thompson S, Sennello R, Young D, Iwata KK, 
Gibson NW, Cagnoni P, Haley JD. Loss of homotypic cell adhesion by 
62 
 
epithelial-mesenchymal transition or mutation limits sensitivity to epidermal 
growth factor receptor inhibition. Mol Cancer Ther. 2007 ;6(2):532-41. 
 
Calalb, T. R. Polte, and S. K. Hanks, “Tyrosine phosphorylation of focal 
adhesion kinase at sites in the catalytic domain regulates kinase activity: a role 
for Src family kinases,”Molecular and Cellular Biology 1995;  vol. 15, no. 2, 
pp. 954–963,. 
 
Cadwell, C., Yoon, H.J., Zebarjadian, Y., Carbon, J. The yeast nucleolar 
protein Cbf5p is involved in rRNA biosynthesis and interacts genetically with 
the RNA polymerase I transcription factor RRN3. Mol. Cell Biol. 1997; 17: 
6175-6183. 
 
Campisi,J .Senescent cells, tumor suppression, and organismal aging: good 
citizens, bad neigh bors Cell. 2005;120 (4):513-22. 
 
Carrillo, J., Gonzalez, A., Manguan-Garcıa, C., Pintado-Berninches, L., 
Perona, R.. p53 pathway activation by telomere attrition in X-DC primary 
fibroblasts occurs in the absence of ribosome biogenesis failure and as a 
consequence of DNA damage. Clin Transl Oncol. 2014; 16(6):529-38. 
 
Cavaillé J1, Buiting K, Kiefmann M, Lalande M, Brannan CI, Horsthemke B, 
Bachellerie JP, Brosius J, Hüttenhofer A.Identification of brain-specific and 
imprinted small nucleolar RNA genes exhibiting an unusual genomic 
organization. Proc Natl AcadSci U S A. 2000;97(26):14311-6 
 
Chan SR, Blackburn EH. Telomeres and telomerase. Philos TransR Soc 
London B BiolSci 2004; 359: 109–121. 
 
Cohen, S.B., Graham, M.E., Lovrecz, G.O., Bache, N., Robinson, P.J., Reddel, 
R.R. Protein composition of catalytically active human telomerase from 
immortal cells. Science 2007;.315: 1850-1853.  
 
Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A, Dokal I. A novel 
DKC1mutation, severe combined immunodeficiency (T+B-NK- SCID) and 
bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. 
Br JHaematol. 2002; 119(3):765-8 
 
Cotter TG. Apoptosis and cancer: the genesis of a research field. Nat Rev 
Cancer. 2009 ;9(7):501-7.  
 
Derenzini M, Montanaro L, Chilla A, Tosti E, Vici M, Barbieri S, et al. Key 
role of the achievement of an appropriate ribosomal RNA complement for G1-




Dez, C., Noaillac-Depeyre, J., Caizergues-Ferrer, M., Henry, Y. Naf1p, an 
essential nucleoplasmic factor specifically required for accumulation of box 
H/ACA small nucleolar RNPs. Mol. Cell Biol 2002; 22: 7053-7065. 
 
Digman MA, Brown CM, Horwitz AR, Mantulin WW, Gratton E.Paxillin 
dynamics measured during adhesion assembly and disassembly by correlation 
spectroscopy. Biophys J. 2008; 94(7):2819-31.  
 
Dokal, I., Bungey, J., Williamson, P., Oscier, D., Hows, J., Luzzatto, 
LDyskeratosiscongenita fibroblasts are abnormal and have unbalanced 
chromosomal rearrangements. Blood .1992;  80: 3090-3096. 
 
Dusek RL1, Attardi LD. Desmosomes: new perpetrators in tumour 
suppression. Nat Rev Cancer. 2011;11(5):317-23 
 
Ender, C., Krek, A., Friedländer, M.R., Beitzinger M., Weinmann, L., Chen, 
W., Pfeffer, S,.Rajewsky, N., Meister, G. A human snoRNA with microRNA-
like functions .Mol. Cell  2008; 32: 519-528. 
 
Fanning AS, Anderson JM. Protein modules as organizers of membrane 
structure.CurrOpin Cell Biol. 1999 Aug;11(4):432-9 
 
Fatica, A., Dlakic, M., and Tollervey, D. Naf1p is a box H/ACA snoRNP 
assembly factor. RNA 2002;. 8: 1502-1514. 
 
Ge, J., Yu, Y.TRNA pseudouridylation: new insights into an old modification. 
Trends Biochem. . 2013;.. 38: 210-218. 
 
Giannone, G., Me` ge, R. M. and Thoumine, OMulti-level molecular clutches 
in motile cell processes. Trends Cell Biol. .2009;.19: 475-486. 
 
Gingras A, Vogel K, Steinhoff H, Ziegler W, Patel B, Emsley J et al.. 
"Structural and dynamic characterization of a vinculin binding site in the 
talinrod".Biochemistry  2006; 45 (6): 1805–17. 
 
Giordano, E., Peluso, I., Senger, S., Furia M. (1999). minifly, a Drosophila 
gene required for ribosome biogenesis. J. Cell. Biol. 144, 1123-1133. 
  
Gu, B.W., Ge, J., Fan, J.M., Bessler, M., Mason, P.J. Slow growth and unstable 
ribosomal RNA lacking pseudouridine in mouse embryonic fibroblast cells 
expressingcatalytically inactive dyskerin. FEBS Lett. 2013;. 58: 2112-2117. 
 
Gumbiner, B., Stevenson, B. and Grimaldi, A. The role of the celladhesion 
molecule uvomorulin in the formation and maintenance of theepithelial 
junctional complex. J. Cell Biol 1988;. 107: 1575-1587. 
64 
 
B. M. Gumbiner, “Cell adhesion: the molecular basis of tissue architecture and 
morphogenesis,” Cell, 1996; .vol. 84, no. 3, pp. 345–357,  
 
Halbleib JM1, Nelson WJ.Cadherins in development: cell adhesion, sorting, 
and tissue morphogenesis. Genes Dev. 2006;20(23):3199-214. 
 
Hazan, R. B., Qiao, R., Keren, R., Badano, I. and Suyama, KCadherin switch 
in tumor progression. Ann. N. Y. Acad. Sci. .2004;. 1014: 155-163. 
 
He, J., Navarrete, S., Jasinski, M., Vulliamy, T., Dokal, I., Bessler, M., Mason, 
P.J. Targeted disruption of Dkc1, the gene mutated in X-linked 
dyskeratosiscongenita, causes embryonic lethality in mice. Oncogene 2002;. 
21: 7740-7744 
 
Heiss, N.S., Knight, S.W., Vulliamy, T.J., Klauck, S.M., Wiemann, S., Mason, 
P.J., Poustka,A., Dokal, I. X-linked dyskeratosis congenita is caused by 
mutations in a highly conserved gene with putative nucleolar functions. Nat. 
Genet. 1998; 19: 32-38. 
 
Honda K1, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H, Yamada Y, Chiba 
H, Hirohashi S.Actinin-4, a novel actin-bundling protein associated with cell 
motility and cancer invasion J Cell Biol. 1998;140(6):1383-93. 
 
Hoog de CL, Foster LJ, Mann M. RNA and RNA binding proteins participate 
in early stages of cell spreading through spreading initiation centers. Cell. 2004 
May 28;117(5):649-62. 
 
Hynes, Integrins: bidirectional, allosteric signaling machines.Cell. 2002 
;110(6):673-87. 
 
F. Hollande, E.M. Blanc, J.P. Bali, R.H. Whitehead, A. Pelegrin, G.S. Baldwin, 
A. Choquet, HGF regulates tight junctions in new nontumorigenic gastric 
epithelial cell line, Am. J. Physiol.: Gasterointest. Liver Physiol. 2001;280: 
G910–92 
 
Humphries P. Wang, C. Streuli, B. Geiger, M. J.Humphries, and C. Ballestrem, 
“Vinculin controls focal adhesion formation by direct interactions with talin 
and actin,” Journal of Cell Biology2007; vol. 179, no. 5, pp. 1043–1057,  
 
Ilic, D., Genbacev, O., Jin, F., Caceres, E., Almeida, E. A., Bellingard 
Dubouchaud, V., Schaefer, E. M., Damsky, C. H., and Fisher, S. J. Am. J. 




Jiang, W., Middleton, K., Yoon, H.J., Fouquet, C., and Carbon, J. An essential 
yeastprotein, CBF5p, binds in vitro to centromeres and microtubules. Mol. 
Cell. Biol. 1993;13:4884-4893. 
 
Jung, C.H., Hansen, M.A., Makunin, I.V., Korbie, D.J., Mattick, 
J.SIdentification of novel non-coding RNAs using profiles of short sequence 
reads from next generation sequencing data. BMC Genomics .2010;. 11:77. 
 
Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y. 
Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA 
damage responses and tumor suppression. Mol Cell Biol. 2005 2:661-70. 
 
Katz BZ, Romer L, Miyamoto S, Volberg T, Matsumoto K, Cukierman E, 
Geiger B, Yamada KM.Targeting membrane-localized focal adhesion kinase to 
focal adhesions: roles of tyrosine phosphorylation and SRC family kinases.J 
Biol Chem. 2003 ;278(31):29115-20.  
 
Kawauchi, T., Sekine, K., Shikanai, M., Chihama, K., Tomita, K., Kubo, K., 
Nakajima, K., Nabeshima, Y. and Hoshino, M. Rab GTPases dependent 
endocytic pathways regulate neuronal migration and maturation through N-
cadherin trafficking. Neuron 2010;. 67: 588-602. 
 
Khotin MG, Turoverova LV, Podol'skaia EP, Krasnov IA, Solov'eva AV, 
AksenovaVIu, Magnusson KE, Pinaev GP, Tentler DG. Analysis of nuclear 
protein complexes comprising alpha-actinin-4 by 2D-electrophoresis and mass-
spectrometry. Tsitologiia. 2009;51(8):684-90. Russian. 
 
Kirwan M and Dokal I. Dyskeratosis congenita, stem cells and telomeres. 
Biochimica Biophysica Acta 2009;1792:371-79 
Kiss, T., E. Fayet, B. E. Jády, P. Richard and M. Weber. Biogenesis and 
intranuclear trafficking of human box C/D and H/ACA RNPs. Cold Spring 
Harb. Symp. Quant.Biol. 2006; 71:407-417. 
 
Kittur, N., Darzacq, X., Roy, S., Singer, R.H., Meier, U.T. Dynamic 
association and localization of human H/ACA RNP proteins. RNA 2006. 12: 
2057-2062. 
 
Knight et al. 1999 Knight, S.W., Heiss, N.S., Vulliamy, T.J., Aalfs, C.M., 
McMahon, C., Richmond, P., Jones,A., Hennekam, R.C., Poustka, A., Mason, 
P.J., Dokal, I. Unexplained aplastic anaemia, immunodeficiency, and cerebellar 
hypoplasia (Hoyeraal-Hreidarssonsyndrome) due to mutations in the 




Lafontaine, D.L., Tollervey, DBirth of the snoRNPs: the evolution of the 
modification-guide snoRNAs. Trends Biochem. Sci. 1998;. 23: 383-388. 
 
.J. Latorre, M.H. Roh, K.K. Frese, R.S. Weiss, B. Margolis, R.T. Javier, Viral 
oncoprotein-induced mislocalization of select PDZ proteins disrupts 
tightjunctions and causes polarity defects in epithelial cells, J. Cell. Sci. 2005; 
118: 4283–4293. 
 
Lin X, Momany M. The Aspergillus nidulans swo C1 mutant shows defects in 
growth and development. Genetics. 2003;165(2):543-54 
 
Liu, B., Zhang, J., Huang, C., Liu, HDyskerin overexpression in human 
hepatocellular carcinoma is associated with advanced clinical stage and poor 
patient prognosis. PLoS One 2012;.7: e43147. 
 
Luzzatto, L., Karadimitris, A. Dyskeratosis and ribosomal rebellion. Nat. Genet 
1998;.19,6-7. 
 
Maceluch, J., Kmieciak, M., Szweykowska-Kulińska, Z., Jarmołowski, A. 
Cloning and characterization of Arabidopsis thaliana AtNAP57 – a homologue 
of yeast pseudouridine synthase Cbf5p. Acta Biochim. P 2001;. 48: 699-709. 
 
Machado-Pinilla, R., Sánchez-Pérez, I., Murguía, J.R., Sastre, L., and Perona, 
R.. A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis 
congenita and in telomerase-deficient human cells. Blood, 2008; 111(5): 2606–
2614. 
 
Maden, B.E. The numerous modified nucleotides in eukaryotic ribosomal 
RNA. Prog.Nucleic Acid. Res. Mol. Biol 1990; 39: 241-303. 
 
Manza, L. L, Codreanu, S.G., Stamer, S.L., Smith, D.L., Wells, K.S., Roberts, 
R.L., Liebler,D.CGlobal shifts in protein sumoylation in response to 
electrophile andoxidative stress. Chem. Res. Toxicol.2004; 17:1706-1715. 
 
Martin T.A., A. Goyal, G. Watkins, W.G. Jiang, Expression of the transcription 
factors snail, slug, and twist and their clinical significance in human 
breastcancer, Ann. Surg. Oncol. 2005; 488–496.25,26 
 
Mason, P.J., Bessler, M. The genetics of dyskeratosiscongenita. Cancer Genet. 
2011; 204: 635-645. 
 
Matise LA, Palmer TD, Ashby WJ, Nashabi A, Chytil A, Aakre M, Pickup 
MW, Gorska AE, Zijlstra A, Moses HL. Lack of transforming growth factor-β 
signaling promotes collective cancer cell invasion through tumor-stromal 
crosstalk. Breast Cancer Res. 2012;14(4):R98.  
67 
 
McDonald, S.L., Edington, H.D., Kirkwood, J.M., Becker, D. Expression 
analysis of genes identified by molecular profiling of VGP melanomas and 
MGP melanoma positive lymph nodes. Cancer. Biol. 2004;. Ther. 3, 110-120. 
 
Me` ge, R. M., Matsuzaki, F., Gallin, W. J., Goldberg, J. I., Cunningham, B. 
A.and Edelman, G. M. Construction of epithelioid sheets by transfection 
ofmouse sarcoma cells with cDNAs for chicken cell adhesion molecules. 
Proc.Natl. Acad. Sci. USA 1988; .85: 7274-7278. 
 
Meier, U.T., Blobel, G. NAP57, a mammalian nucleolar protein with a putative 
homolog in yeast and bacteria. J. Cell Biol. 1994;. 127: 1505-1514. 
 
Millake DB1, Blanchard AD, Patel B, Critchley DR.The cDNA sequence of a 
human placental alpha-actinin. Nucleic Acids Res. 1989;17(16):6725. 
 
 
Mitchell, J.R., Wood, E., and Collins, K. A telomerase component is defective 
in the human disease dyskeratosis congenital. Nature 1999; 402, 551- 
 
MitraS. K. and D. D. Schlaepfer, “Integrin-regulated FAK-Srcsignaling in 
normal and cancer cells,” Current Opinion in CellBiology2006; pp. 516–523,  
 
Mochizuki, Y., He, J., Kulkarni, S., Bessler, M., Mason, P.J. Mouse 
dyskerinmutations affect accumulation of telomerase RNA and small 
nucleolarRNA, telomerase activity, and ribosomal RNA processing. Proc. Natl. 
Acad. Sci. USA 2004; 101:10756-10761 
 
Montanaro, L., Brigotti, M., Clohess, J., Barbieri, S., Ceccarelli, C., Santini, 
D., Taffurelli, M., Calienni, M., Teruya-Feldstein, J., Trerè, D., Pandolfi, P..P, 
Derenzini, M. Dyskerin expression influences the level of ribosomal RNA 
pseudo-uridylation and telomerase RNA component in human breast cancer. J. 
Pathol. 2006;. 210:10-18. 
 
Montanaro, L., Calienni, M., Ceccarelli, C., Santini, D., Taffurelli, M., Pileri, 
S., Treré, D.,Derenzini, MRelationship between dyskerin expression and 
telomerase activity in human breast cancer. Cell Oncol. 2008;  30: 483-490. 
 
Montanaro, L., Calienni, M., Bertoni, S., Rocchi, L., Sansone, P., Storci, G., 
Santini, D.Ceccarelli, C., Taffurelli, M., Carnicelli, D., Brigotti, M., Bonafè, 
M., Treré, D., Derenzini, M. Novel dyskerin mediated mechanism of p53 
inactivation through defective mRNA translation. Cancer Res. 2010;. 70: 4767-
4777. 
 




Newby and Greenbaum Sculpting of the spliceosomal branch site recognition 
motif by a conserved pseudouridine.Nat Struct Biol. 2002  ;9(12):958-65. 
 
Noble, M., Lewis, S. A. and Cowan, N. JThe microtubule binding domain of 
microtubule-associated protein MAP1B contains a repeated sequence motif 
unrelated to that of MAP2 and tau. J. Cell Biol. 1989;. 109: 437-448. 
 
Otey CA, Carpen O. Alpha-actinin revisited: a fresh look at an old 
player.CellMotil Cytoskeleton. 2004 ;58(2):104-11. 
 
Parsons and S. J. Parsons, “Src family protein tyrosinekinases: cooperating 
with growth factor and adhesion signalingpathways,” Current Opinion in Cell 
Biology, 1997;.vol. 9, no. 2,pp. 187–192,  
 
Phillips, B., Billin, A.N., Cadwell, C., Buchholz, R., Erickson, C., Merriam, 
J.R., Carbon, J.Poole, S.J. The Nop60B gene of Drosophila encodes an 
essential nucleolar protein that functions in yeast. Mol. Gen. Genet. 1998;. 260, 
20-29. 
 
Piva, R., Pellegrino, E., Mattioli, M., Agnelli, L., Lombardi, L., Boccalatte, F., 
Costa, G.,Ruggeri, B.A., Cheng, M., Chiarle, R., Palestro, G., Neri, A., 
Inghirami, G. Functional validation of the 
anaplasticlymphomakinasesignatureidentifies CEBPB and BCL2A1 ascritical 
target genes. J Clin. Invest. 2006;.116: 3171-3182. 
 
Pokutta S, Herrenknecht K, Kemler R, Engel J. Conformational changes of the 
recombinant extracellular domain of E-cadherin upon calcium binding.Eur J 
Biochem. 1994;223(3):1019-26. 
 
Qin et al. 2004Integrin bidirectional signaling: a molecular view.Qin J, 
Vinogradova O, Plow EF.PLoS Biol. 2004;2(6):e169. 
 
Ratheesh, A., Gomez, G. A., Priya, R., Verma, S., Kovacs, E. M., Jiang, 
K.,Brown, N. H., Akhmanova, A., Stehbens, S. J. and Yap, A. S. 
Centralspindlin and a-catenin regulate Rho signalling at the epithelial 
zonulaadherens. Nat. Cell Biol 2012; 14:818-828 
 
Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for 
quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005 May 10;5:12. 
 
Richard, P., Kiss, A.M., Darzacq, X., Kiss, T. Cotranscriptional recognition of 
human intronic box H/ACA snoRNAs occurs in a splicing-independent 
manner. Mol. Cell Biol. 2006; 26:2540-2549. 
Rocchi, L., Pacilli, A., Sethi, R., Penzo, M., Schneider, R.J., Treré, D., Bigotti, 
M.,Montanaro, L.. Dyskerin depletion increases VEGF mRNA internal 
69 
 
ribosome entry site-mediated translation. Nucleic Acids Res. 2013; 41: 8308-
8318. 
 
Rowland BD and Peeper DS, KLF4, p21 and context-dependent opposing 
forces in cancer Nature Reviews Cancer 2006;6: 11-23  
 
Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P.H., Cordon-
Cardo, C.,Pandolci, P.P.. Dyskeratosis congenita and cancer in mice deficient 
in ribosomal RNA modification. Science 2003;299: 259-262. 
 
Saraiya, A.A., Wang, C.C. snoRNA, a novel precursor of microRNA in 
Giardia lamblia. PLoSPathog 2008;. 4,e1000224 
 
Sastry SK, Burridge K. Focal adhesions: a nexus for intracellular signaling and 
cytoskeletal dynamics. Exp Cell Res. 2000;261:25–36. 
 
Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP. TINF2, a 
component of the shelterin telomere protection complex, is mutated 
indyskeratosiscongenita. Am J Hum Genet. 2008; 82(2):501-9 
 
Schaller, C. A. Otey, J. D. Hildebrand, and J. T. Parsons, “Focal adhesion 
kinase and paxillin bind to peptides mimicking βintegrin cytoplasmic 
domains,” Journal of CellBiology1995; vol. 130, no. 5, pp. 1181–1187,. 
 
Schaner, M.E., Ross, D.T., Ciaravino, G., Soglie, T., Troyanskaya, O., et al. 
Gene expression patterns in ovarian carcinomas. Mol. Biol. Cell 2003; 14, 
4376-4386. 
 
Shin S, Wolgamott L, Yoon SO.Integrin trafficking and tumor progression. 
Int J Cell Biol. 2012;2012:516789 
 
Sieron, P., Hader, C., Hatina, J., Engers, R., Wlazlinski, A., Müller, M., 
Schulz, W.A. DKC1 overexpression associated with prostate cancer 
progression. Br. J. Cancer 2009; 101:1410-1416. 
 
Sjöblom B, Ylänne J, Djinović-Carugo K.Novel structural insights into F-actin-
binding and novel functions of calponin homology domains.CurrOpinStruct 
Biol. 2008 Dec;18(6):702-8.  
 
Taft, R.J., Glazov, E.A., Lassmann, T., Hayashizaki, Y., Carninci, P., Mattick, 
J.S. Small RNAs derived from snoRNAs. RNA 2009;15: 1233-1240 
 
Tortoriello, G., de Celis, J.F., Furia, M. Linking pseudouridine synthases to 




Tracey LA. Martin, , Wen G. Jiang loss of tight junction barrier function and 
its role in cancer metastasisT.A. Martin, W.G. Jiang / Biochimica et 
BiophysicaActa 2009; 1788 :872–891 
 
Tsukita S., M. Furuse, Occludin and claudins in tight-junction strands: leading 
or supporting players? Trends Cell Biol. 1999; 9:  268–273. 
 
Turano, M., Angrisani, A., De Rosa, M., Izzo, P., Furia, M.. Real-time PCR 
quantification of human DKC1 expression in colorectal cancer. Acta Oncol 
2008;  47: 1598-1599 
 
Turano, M., Angrisani, A., Di Maio, N., Furia, M. Intron retention: a human 
DKC1 gene common splicing event. Biochem. Cell Biol 2013; 91:506-512. 
 
Turksen K, Troy TC.Junctions gone bad: claudins and loss of the barrier in 
cancer. BiochimBiophysActa. 2011 Aug;1816(1):73-9.  
 
Vicidomini R, Di Giovanni A, Petrizzo A, Iannucci LF, Benvenuto G, Nagel 
AC, Preiss A, FuriaM. Loss of Drosophila pseudouridine synthase triggers 
apoptosis-induced proliferation and promotes cell-nonautonomous EMT. 
Cell Death Dis. 2015;6:e1705.  
Virel A, Backman L.Molecular evolution and structure of alpha-actinin. 
MolBiolEvol. 2004;21(6):1024-31 
Vlodavsky, G. M. Lui, and D. Gospodarowicz, “Morphological appearance, 
growth behavior and migratory activity of human tumor cells maintained on 
extracellular matrix versus plastic,” Cell, 1980.vol. 19, no. 3, pp. 607–616,  
 
Vulliamy,T. J., Knight, S. W., Heiss,.N. S., Smith, O. P., Poustka, A., Dokal, 
I., Mason, P. J . Dyskeratosiscongenita caused by a 3' deletion: germline and 
somatic mosaicism in a female carrier. Blood 1999; 94:1254-1260 
 
Vulliamy, Marrone A, Goldman F,Dearlove A, Bessler M, Mason PJ, Dokal 
I.The RNA component of telomerase is mutated in autosomal dominant 
dyskeratosiscongenita.Nature.2001;413(6854):432-5 
 
Watanabe, Y., Gray, M.W. Evolutionary appearance of genes encoding 
proteins associated with box H/ACA snoRNAs: cbf5p in Euglena gracilis, an 
early diverging eukaryote, and candidate Gar1p and Nop10p homologs in 
archaebacteria. Nucleic Acids Res. 2000;28:2342-2352. 
 
Westermann, F., Henrich, K.O., Wei, J.S., Lutz, W., Fischer, M., König, R., 
Wiedemeyer, R., Ehemann, V., Brors, B., Ernestus, K., Leuschner, I., Benner, 
71 
 
A., Khan, J., Schwab, M.. High Skp2 expression characterizes high-risk 
neuroblastomas independent of MYCN status. Clin. Cancer Res. 2007; 13: 
4695-4703. 
 
Westman, B.J., Verheggen, C., Hutten, S., Lam, Y.W., Bertrand, E., Lamond, 
A.I. A proteomic screen for nucleolar SUMO targets shows SUMOylation 
modulates the function of Nop5/Nop58. Mol. Cell 2010; 39:618-631. 
 
Witkowska, A., Gumprecht, J., Glogowska-Ligus, J., Wystrychowski, G., 
Owczarek, A., Stachowicz, M., Bocianowska, A., Nowakowska-Zajdel, E., 
Mazurek, U.. Expression profile of significant immortalization genes in colon 
cancer. Int. J. Mol.Med 2010; 25: 321-329. 
 
Wong and Collins, Telomerase RNA level limits telomere maintenance in X-
linked dyskeratosiscongenita.Genes Dev. 2006;20(20):2848-58.  
 
Wong V., B.M. Gumbiner, A synthetic peptide corresponding to the 
extracellular domain of occludin perturbs the tight junction permeability 
barrier, J. Cell Biol. 1997; 136: 399–409. 
 
Yang, Y., Isaac, C., Wang, C., Dragon, F., Pogacic, V., Meier, U.T. Conserved 
composition of mammalian box H/ACA and box C/D small nucleolar 
ribonucleoprotein particles and their interaction with the common factor 
Nopp140. Mol. Biol. Cell. 2000;. 11: 567-577. 
 
Yeaman C, Grindstaff KK, Nelson WJ. New perspectives on mechanisms 
involved in generating epithelial cell polarity. Physiol Rev. 1999 Jan;79(1):73-
98.  
 
Yoon, A., Peng, G., Brandenburger, Y., Zollo, O., Xu, W., Rego, E. and 
Ruggero, D. Impaired control of IRES-mediated translation in X-linked 
dyskeratosis congenital. Science 2006; 312:902-906. 
 
Yoon, Robert D. Moir, VeenaPrahlad, and Robert D. Goldman 
NorthwesternMotile Properties of Vimentin Intermediate FilamentNetworks in 
Living Cells J Cell Biol. 1998; 143(1):147-57.  
 
Youssoufian H, McAfee M, Kwiatkowski DJ. Cloning and chromosomal 
localization of the human cytoskeletal alpha-actinin gene reveals linkage to the 
beta-spectrin gene. Am J Hum Genet. 1990 ;47(1):62-72. 
 
Yu, A.T., Ge, J., Yu, Y.T.. Pseudouridines in spliceosomal snRNAs. Protein 




Zhang, Y., Morimoto, K., Danilova, N., Zhang, B., Lin, S.. Zebrafish models 
for dyskeratosiscongenita reveal critical roles of p53 activation contributing to 
hematopoietic defects through RNA processing. PLoS One 2012; 7: e30188.  
 
Zebarjadian, Y., King, T., Fournier, M.J., Clarke, L., Carbon, J.. Point 
mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA. Mol. 
Cell Biol. 1999; 19: 7461-7472 
 
Zhao X, Hsu KS, Lim JH, Bruggeman LA, Kao HY.J α-Actinin 4 potentiates 
nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in 
podocytes independent of its cytoplasmic actin binding function.Biol Chem. 
2015;290(1):338-49.  
 
ZimermanB1, Volberg T, Geiger B.Early molecular events in the assembly of 
the focal adhesion-stress fiber complex during fibroblast spreading.Cell Motil 








































Intron retention: a human DKC1 gene common splicing event
Mimmo Turano, Alberto Angrisani, Nunzia Di Maio, and Maria Furia
Abstract: Identiﬁcation of alternatively spliced transcripts produced by a gene is a crucial step in deciphering the bulk of its
biological roles and the overall processes that regulate its activity. By using a combination of bioinformatic and molecular
approaches we identiﬁed, cloned, and characterized 3 novel alternative splice isoforms derived from human dyskeratosis
congenita 1 (hDKC1), an essential human gene causative of the X-linked dyskeratosis congenita disease and involved in multiple
functions related to cell growth, proliferation, and telomere maintenance. Expression of the new isoforms, all characterized by
intron retention, was conﬁrmed by RT-PCR in a panel of diverse cell lines and normal human tissues, and despite the presence
of premature termination codons, was not down-regulated by the mechanism of nonsense-mediated decay. Accumulation of
these transcripts ﬂuctuated distinctly in the diverse tissues and during in vitro differentiation of Caco2 cells, suggesting that
their ratio may contribute to the gene functional diversity across different cell types. Intriguingly, the structure of one isoform
leads to exonize an intronically encoded small nucleolar RNA (snoRNA), highlighting an additional layer of complexity that can
contribute to overall gene regulation.
Key words: alternative splicing, dyskerin, DKC1, pseudouridine synthase, snoRNP.
Résumé : L’identiﬁcation de transcrits géniques sujets a` l’épissage alternatif est une étape clé aﬁn de décrypter l’essentiel de
leurs rôles biologiques et les processus globaux qui régulent leur activité. En utilisant une combinaison d’approches bioinfor-
matiques et moléculaires, nous avons identiﬁé, cloné et caractérisé trois nouvelles isoformes épissées de manière alternative
issues du gène hDKC1 (human dyskeratosis congenita 1), un gène essentiel qui cause la dyskératose congénitale liée au chromosome
X et qui impliqué dans plusieurs fonctions reliées a` la croissance cellulaire, a` la prolifération et au maintien des telomeres.
L’expression des nouvelles isoformes, toutes caractérisées par une rétention d’intron, a été conﬁrmée par RT-PCR dans une série
de lignées cellulaires différentes et de tissus humains normaux et, malgré la présence de codons de terminaison prématurés,
cette expression n’était pas régulée a` la baisse par un mécanisme de dégradation d’ARNm non-sens. L’accumulation de ces
transcrits ﬂuctuait distinctement dans les différents tissus et pendant la différenciation in vitro des cellules Caco2, suggérant que
leur rapport peut contribuer a` la diversité génique fonctionnelle parmi les différents types cellulaires. Fait intéressant, la
structure d’une isoformemène a` l’exonisation d’un petit ARN nucléolaire (snoARN) codé dans un intron, mettant en lumière un
niveau additionnel de complexité qui peut contribuer a` la régulation génique générale. [Traduit par la Rédaction]
Mots-clés : épissage alternatif, dyskérine, DKC1, pseudouridine synthase, snoARN.
Introduction
In the human transcriptome, current analyses pointed out that
92%–94% of humanmulti-exon genes undergo alternative splicing
(AS) (Pan et al. 2006; Wang et al. 2008). Among diverse types of AS,
intron retention (IR) has been observed for at least 41% of human
genes, and it has been suggested that it may represent a speciﬁc
hallmark of primate genomes (Mollet et al. 2010). Here we focused
on the repertory of IR transcripts derived from hDKC1, an essential
and ubiquitously expressed human gene involved in multiple
functions related to cell growth and proliferation. hDKC1 loss of
function mutations cause X-linked dyskeratosis congenita, a syn-
drome characterized by a plethora ofmanifestations that includes
bone marrow failure, stem cell dysfunction, premature aging,
and increased susceptibility to cancer (Kirwan and Dokal 2009).
An ubiquitous nucleolar protein, named dyskerin (Heiss et al.
1998), and a truncated dyskerin variant localized in the cytoplasm
(Angrisani et al. 2011) are known to be encoded by this gene.
Dyskerin participates in two essential nuclear ribonucleoprotein
complexes. Through its PUA domain, which recognizes the H/ACA
RNA motif of human telomerase RNA component, the protein
takes part in the active telomerase complex and plays a key role in
telomere maintenance (Kirwan and Dokal 2008). The same PUA
domain allows dyskerin to recognize snoRNAs containing H/ACA
sequences, and its early association to these nascent molecules
stabilizes them throughout their biogenesis and assembly into
H/ACA small nucleolar RNA ribonucleoproteins (snoRNPs), upon
subsequent interaction with additional core proteins (Kiss et al.
2010; Alawi and Lin 2010). This chaperoning role is acquiring grow-
ing importance since snoRNAs, besides acting in RNA modiﬁca-
tion processes, can be processed to generate microRNAs (Ender
et al. 2008) or short regulatory RNAs able to modulate alternative
splicing (Khanna and Stamm 2010). H/ACA snoRNPs are involved
in both processing and pseudouridylation of rRNA, and thus play
an essential role in ribosome biogenesis. Within these complexes,
dyskerin acts as pseudouridine synthase and catalyses the conver-
sion of speciﬁc uridine residues to pseudouridines on rRNAs and
snRNAs (Kiss et al. 2010). Pseudouridylation represents the most
abundant type of RNA modiﬁcation occurring in eukaryotic cells
and is known to be required for the translation ﬁdelity of the
ribosome (Jack et al. 2011) and efﬁcient activity of the spliceosome
(Yu et al. 2011).
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In addition to the above mentioned dual canonical functions,
hDKC1 is thought to be involved in a variety of diverse cellular pro-
cesses, such as nucleo-cytoplasmic shuttling (Meier and Blobel 1994),
DNAdamage response (Guet al. 2009), and cell adhesion (Sieronet al.
2009; Alawi and Lin 2011; Angrisani et al. 2011), although the exact
role played in each of them remains to be elucidated. The functional
versatility of this gene is further underlined by its codingnon-coding
interlaced organization, a feature that is shared by its mouse (http://
genome.ucsc.edu/) andDrosophila (Riccardo et al. 2007) orthologues.
Speciﬁcally, hDKC1 hosts two snoRNAs of the H/ACA class, named
SNORA36A and SNORA56, in introns 8 and 12, respectively. Both
these snoRNAs have veriﬁed targets on rRNAs (http://www-snorna.
biotoul.fr/); in addition, SNORA56 acts as precursor of a microRNA
witha so farundetermined function (Ender et al. 2008). This complex
structural organization suggested that AS events could also modu-
late the expression of the intronically hosted snoRNAs, adding




The human EST databases at the NCBI were searched by the
BLAST algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi) entering the
hDKC1 human genomic sequence (GenBank ID: NC_000023). Clust-
alW (http://align.genome.jp/) was used to verify positivematches and
putativeCDSswere evaluatedby the translate tool at theExPASyweb
site (http://web.expasy.org/translate/).
Cell culture and treatment
Colorectal adenocarcinoma (Caco2), cervical carcinoma (HeLa), os-
teosarcoma (U-2 OS), breast adenocarcinoma (MCF7), and liver carci-
noma (Hep G2) human cell lines were obtained from ATCC and
cultured following the suggested conditions. To check nonsense-
mediated decay (NMD) susceptibility, translation was blocked by
treating cells with cycloheximide (100 g/mL) up to 4 h, as described
in (Cuccurese et al. 2005). All media and supplements were pur-
chased from Sigma-Aldrich (St. Luis, Mo., USA). For gene silencing,
MCF7 cells were transiently transfected using 3 g of shRNA (hDKC1)
lentiviral plasmid pLKO.1-puro (Sigma) or pLKO.1-puro empty vector,
and 30 L of Cellfectin (Invitrogen), following manufacturer’s in-
structions. Selected shRNA (TATGTTGACTACAGTGAGTCTCTCGAG
AGACTCACTGTAGTCAACATA) targeted hDKC1 exon 12–13 junction,
which is shared by isoform 1 and all newly described isoforms.
RNA extraction and analysis
RNA isolation, cDNA synthesis, RT-PCR fragments cloning, and
semiquantitative RT-PCR analyses of human tissues and cell lines
were carried out as previously described (Angrisani et al. 2011).
Poly (A)+ fraction was obtained using Genelute mRNA miniprep
kit (Sigma-Aldrich, St. Luis, Mo., USA) following manufacturer’s
instructions. To obtain nuclear and cytoplasmic RNAs, cellular
pellet was lysed in 20 mmol/L TrisHCl pH 8.0, 85 mmol/L KCl,
0.5% NP40; after incubation on ice (15 min), nuclei were separated
from cytoplasmic fraction by centrifuging at 3000g for 5 min
and RNA extracted from each fraction. To avoid gDNA ampliﬁca-
tion, RNAs were subjected to treatment with RQ1 DNase (Promega,
Madison,Wis., USA). The cycle numbers of semiquantitative analysis
were: 28 for Iso 1 and largest subunit of RNA polymerase II, 32 for
Iso 5, and 37 for Iso 4 and Iso 6. qRT-PCR experiments were per-
formed as previously described (Turano et al. 2008); the data were
normalized to the expression of the human glutathione synthetase
housekeeping gene (De Rosa et al. 2007). After normalization, the
data are presented as fold change relative to the reference point. To
determine the absolute quantity of hDKC1 isoforms, standard curves
were obtained by preparing 10-fold serial dilutions of plasmids (pGEM
T-Easy Vector, Amersham) containing cDNA sequences of each iso-
form. Sequencesof all theprimers are listed inSupplementary Fig. 1.1
Results and discussion
Identiﬁcation and cloning of hDKC1 intron-retaining
transcripts
To identify IR transcripts derived from the hDKC1 gene, we deep-
ened the BLAST analysis of the human EST database, using as
query all gene introns. This analysis revealed 4 EST clusters char-
acterized by total or partial retention of a speciﬁc intron (Fig. 1A).
To rule out the possibility that these ESTs represented partially
spliced intermediates, we ﬁrst conﬁrmed their actual expression
by RT-PCR analysis of total RNA obtained from epithelial Caco2
cells. Each EST type was found be actively expressed, so we at-
tempted to extend their upstream and downstream regions by a
double PCR reaction on cDNA (schematized in Supplementary
Fig. 1)1. In the ﬁrst PCR reactions, a forward primer annealing on
the gene 5= UTR was coupled to reverse primers annealing on the
intron speciﬁcally retained by the annotated EST; in the second
PCR reactions, divergent forward primers annealing on the spe-
ciﬁc intron were coupled to a reverse primer annealing on hDKC1
last exon. Following this approach, we failed to obtain any
RT-PCR extended product representative of intron 7-retaining
transcript, although ESTs of this type have been annotated from
at least 6 different tissue sources. Moreover, we were able to re-
producibly amplify short RT-PCR fragments retaining this speciﬁc
intron, indicating that a related transcript was effectively pro-
duced in Caco2 cells. The inability to obtain extended ampliﬁca-
tion products thus remains unclear and might be related to a
more complex and unexpected organization of the associated
transcript. Productive ampliﬁcationwas instead obtained for each
other EST type, so that cloning and sequencing of the obtained
fragments led to deﬁne the structure of 3 new AS transcripts,
hereafter named isoforms 4, 5, and 6, all characterized by reten-
tion of a speciﬁc intron within an otherwise fully spliced RNA
(GenBank Accession numbers: KC954523, KC954524, KC954525,
respectively; see Fig. 1B). It has been observed that human tran-
scripts characterized by IR derive preferentially from highly and
broadly expressed genes (Sakabe and de Souza 2007), and that the
majority of them (78%) retain a single intron within mature RNAs
(Mollet et al. 2010); the hDKC1 new isoforms all conform to these
general features. Isoforms 4 and 5wholly retained introns 2 and 5,
respectively, while isoform 6 originated from activation of an
intron 8-internal cryptic donor splice site (Fig. 1B). This event leads
to exonize SNORA36A sequence, linking the expression of this
transcript to the biogenesis of this snoRNA. Since the previously
described hDKC1 isoform 3 led to exonization of SNORA56 se-
quence (Angrisani et al. 2011), it is plausible that IR events can
have a general role in coupling the regulation of hDKC1 expression
to that of its hosted snoRNAs. This view is further supported by
the ﬁnding that a signiﬁcant subset of human retained introns
hosts snoRNAs, or other small non-coding RNAs, and transcripts
retaining these introns were found also in the cytoplasm (Mollet
et al. 2010). Consistent with these observations, isoform 6 was
detected in the poly(A)+ fraction and enriched in preparations of
cytoplasmic RNA (see Fig. 2), despite that the IR event was ex-
pected to affect its nuclear export. It has been suggested that
regulation of splicing and biogenesis of small intronic non-coding
RNAs could be interconnected (Mollet et al. 2010), although it is
not yet clear whether cytoplasmic transcripts retaining intronic
non-coding RNAs can act as precursors, or conversely, their ex-
pression could antagonize the biogenesis of these molecules. As
concerning intronic H/ACA snoRNAs, the view that splice site se-
1Supplementary data are available with the article through the journal Web site at http://nrcresearchpress.com/doi/suppl/10.1139/bcb-2013-0047.
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lection and snoRNA recognition are concomitant and possibly
interlaced events was ﬁrst suggested by the observation that re-
cruitment of both H/ACA snoRNP proteins and splicing factors
occur cotranscriptionally on pre-mRNAs (Richard et al. 2006).
A main question is whether the new hDKC1 isoforms, all detected
in the poly(A) + fraction, represent long, translationally unproduc-
tive non-coding RNAs, or can be translated in variant proteins with
possible biological functions. Looking at their coding properties, we
noticed that these transcripts were characterized by the presence of
premature stop codons (PTCs) that interrupted dyskerin CDS prema-
turely (Fig. 1B). The coding potential of isoform 4 was very low, with
dyskerin CDS precociously interrupted within intron 2; isoforms 5
and 6 could instead be able to encode putative proteins of 159 aa
(18 kDa) and 313 aa (35.1 kDa), respectively. However, both proteins
would lack the PUA domain, which is essential for human telomer-
ase RNA component and snoRNA recognition, and the C-terminal
nuclear localisation signal, which is required for snoRNP assembly
(Machado-Pinilla et al. 2008) and preeminent nuclear localization
(Angrisani et al. 2011); consequently, they would be unable to carry
out the dual dyskerin canonical functions. However, an alternative
functional role playedby these truncatedproteinsmight bebasedon
their ability to encode an internal dyskerin peptide, named GSE24-2
(90–144 aa). Expression of this peptide was reported to be able to
increase telomerase activity, block senescence, and recover the
dividing capacity of X-linked dyskeratosis congenita cells. Intri-
guingly, these effects were not reproduced by full-length dyskerin
(Machado-Pinilla et al. 2008). Since it is plausible that other dyskerin
regions could block GSE24-2 activity, we considered the possibility
that truncated dyskerin variants may be able to direct synthesis of
this peptide within an active protein context. To investigate this
aspect, we checked whether splice isoforms were enriched in cyto-
solic RNA preparations. As shown in Fig. 2, we found that isoforms 4
and 5 were essentially retained in the nuclei, while isoform 6, to-
gether with canonical isoform 1, was efﬁciently exported in the cy-
toplasm. Active expression of this isoformwas further conﬁrmed by
gene silencing experiments; in fact, when cells were transiently
transfected with a plasmid bearing a shRNA targeting sequences
common to isoforms 1 and 6 (see Methods section), both transcripts
were silenced at a comparable degree (see Supplementary Fig. 2)1.
It is worth noting that the putative isoform 6-encoded protein
shares only its ﬁrst 257 aa with dyskerin but exhibits an unique,
highly hydrophobic C-terminal tail of 56 aa (see Supplementary
Fig. 3)1 thatmight be involved in novel protein–protein interactions.
Remarkably, the overall structure of this protein is highly reminis-
cent of that previously described for a variant protein encoded by
mﬂ/Nop60b, the hDKC1 Drosophila orthologue (Riccardo et al. 2007),
which is similarly characterized by a unique, hydrophobic C-terminal
domain (see Supplementary Fig. 3)1.
hDKC1 intron-retaining transcripts are actively expressed in
diverse cell lines and normal tissues and are differently
regulated during in vitro Caco2 cell differentiation
Expression proﬁling of new IR transcripts was deﬁned by semi-
quantitative RT-PCR analysis of a panel of human cell lines and
normal tissues. All hDKC1 isoforms were detected, although at
variable levels, in each tested cell line (Fig. 3A). Absolute quanti-
tation of each isoformwas determined in Caco2 cells (Supplemen-
tary Table 1)1 and showed that abundance of these rare variants
ranged from about 20- to 70-fold less than that of canonical iso-
form 1. In vivo expression was also conﬁrmed in a panel of
20 diverse tissues (Fig. 3B), including placenta, where the GSE24-2
peptide was identiﬁed upon screening of a library enriched for
low-abundance mRNAs (Machado-Pinilla et al. 2008). The expres-
sion levels ﬂuctuate distinctly in the diverse tissues, suggesting
that hDKC1 multiple isoforms may contribute to the gene func-
tional diversity across differentiated cell types. Quantitative den-
Fig. 1. Structure of intron-retaining hDKC1 transcripts. (A) List of annotated ESTs representative of new hDKC1 splice isoforms. The accession
number (http://www.ncbi.nlm.nih.gov/nucest/) of each annotated EST is indicated; # marks the longest EST of each group, whose structures
are depicted in Fig. 1B; * indicates that intron 8, whose whole length is 734 nt, is only partially retained (370 nts) by this isoform. (B) On the
top, the structure of the 2.6 kb hDKC1 mRNA (iso 1) encoding canonical dyskerin (GenBank ID: NM_001363). Exons are depicted as boxes, cod-
ing regions are in black; the position of the main dyskerin functional domains is indicated above, together with that of the intronically en-
coded SNORA36A and SNORA56. Below, structures of the ESTs marked with # and their related transcripts, as derived by RT-PCR cloning
(see Supplementary Fig. 1)1 and nucleotide analysis.
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sitometric analyses (Fig. 3C) indicated that the various transcripts
reached their maximum level of expression in different tissues,
with the canonical isoform 1 being up-regulated in thyroid, iso-
forms 4 and 5 in colon, and isoform 6 in foetal brain.
Since regulation of AS plays critical roles in cell differentiation
(Dujardin et al. 2013), we analysed by qRT-PCR the expression of
various hDKC1 transcripts, including that of the previously de-
scribed isoform 3 (Angrisani et al. 2011), during in vitro differen-
tiation of Caco2 cells. These cells undergo in long term culture a
process of spontaneous differentiation that leads to the expres-
sion of several morphological, functional and biochemical char-
acteristics of small intestinal enterocytes. Differentiation starts as
soon as conﬂuence is reached (Pinto et al. 1983) and markedly
inﬂuences the accumulation levels of mRNAs encoded by human
apolipoprotein Al and human sucrose isomaltase genes, whose
quantiﬁcation provides a sensitive and reliable molecular marker
of the process (Pinto et al. 1983; Reisher et al. 1993). RNA was then
extracted on day 3 (taken as reference point for undifferentiated
cells) and day 14 (taken as reference point for fully differentia-
ted cells) of growth, and the levels of human apolipoprotein Al
and human sucrose isomaltase mRNAs were used as markers of
enterocyte-like differentiation (Fig. 4A). As shown in Fig. 4B, ex-
pression of the various isoforms was differently modulated upon
differentiation, with isoforms 1 and 4 undergoing a reduction, and
isoforms 3, 5, and 6 increasing their expression in fully differen-
tiated cells. These data are consistent with the diverse proﬁling
observed in the different tissues, and support the view that differ-
entiation processes can inﬂuence the expression of hDKC1 multi-
ple transcripts.
hDKC1 multiple isoforms escape the NMD-triggered decay
Alternative splicing plays a fundamental role in increasing tran-
scriptome complexity, not only by changing function, abundance,
and localization of the encoded products (Kelemen et al. 2013), but
also generating nonfunctional transcripts that can determine a
global down-regulation of gene function, or act as long non-
coding RNAs with diverse regulatory roles (Rinn and Chang 2012).
Since all newly identiﬁed transcripts, similarly to the previously
Fig. 2. Comparative estimate of the levels reached by each new hDKC1 isoform in nuclear and cytosolic fractions. (A) Abundance of each
isoform was determined by qRT-PCR analysis; the snoRNA SNORA62 was used as a nuclear marker, while GSS mRNA was used as marker of the
cytosolic fraction. Expression was normalized with respect to POLR2A mRNA. (B) Agarose gel of 800 ng fractionated RNA; M 1 kb DNA ladder
(Applichem), N nuclear RNA, C Cytoplasmic RNA. (C) Semiquantitative RT-PCR of SNORA62 nucleolar RNA; M 100 bp Plus DNA ladder
(Applichem), N nuclear, C Cytoplasmic.
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described isoform 3 (Angrisani et al. 2011), were characterized by
PTCs residing beyond 50 nt 5= to an exon junction, the NMD sur-
veillance mechanism was expected to commit them to a rapid
degradation (Gardner 2010). To assess whether hDKC1 isoforms
could be down-regulated by NMD, we analysed by qRT-PCR the
total RNA obtained from Caco2 cells untreated or treated with
cycloheximide, an inhibitor of protein synthesis that inactivates
translationally active ribosomes and represses NMD. RNA samples
were collected at 2 time points from the treatment and normal-
izedwith respect to the level of the human glutathione synthetase
Fig. 3. Widespread expression of intron-retaining hDKC1 transcripts. Expression of various isoforms was checked by semiquantitative RT-PCR
analysis in panels of 5 different human cell lines (A). Active expression was also observed in a panel of 20 human tissues (B), together with
that of the 2.6 kb transcript encoding canonical dyskerin (Iso 1). A comparative estimate of the levels reached by each hDKC1 isoform in the
diverse tissues was obtained by densitometric analyses (C). The table lists the values obtained for each isoform in a speciﬁc tissue; (below)
these values were normalized respect to that obtained in the same tissue for the hPOLR2A gene, used as internal control. Normalised data were
used to calculate a mean value (taken as representative of the average level of each speciﬁc isoform). Variations from the mean value more
than 2 sigma limits were considered signiﬁcant and taken as indexes of speciﬁc peaks of expression; for each isoform, peak values are marked
in italic bold.
Fig. 4. Expression of hDKC1 intron-retaining isoforms during in vitro differentiation of Caco2 cells. (A) Human apolipoprotein Al (hAPOA1)
and human sucrose isomaltase (hSI) mRNA levels were used as markers of enterocyte-like differentiation. (B) Total RNA was extracted and
analysed by qRT-PCRs on days 3 (undifferentiated cells) and 14 (differentiated cells) of cell growth. The expression of the canonical dyskerin-
coding transcript (Iso 1) is also reported. Data are presented as means ± SD from 3 independent experiments, each performed in triplicate.
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housekeeping mRNA; the expression of hrpL3-a, an alternatively
spliced form of the hrpL3 gene that is known to be under the
control of NMD (Cuccurese et al. 2005), was employed as positive
control of the NMD block. While hrpL3-a mRNA accumulated ef-
ﬁciently in cells exposed to cycloheximide, as expected for an
NMD-regulated transcript, the levels of all hDKC1 isoforms, irre-
spective of the presence of PTCs, were found to be unaffected by
the treatment, showing that also the cytoplasmic isoform 6 is
immune to this surveillance mechanism (Fig. 5). Several PTC-
containing mRNAs are immune to the NMD machinery and en-
code proteins with biological activity (Pan et al. 2006), including
hDKC1 isoform 3 (Angrisani et al. 2011), supporting the possibility
that also this new hDKC1 isoform may be translated.
Conclusions
Among the diverse types of AS events, IR has been suggested to
represent a speciﬁc hallmark of primate genomes (Mollet et al.
2010). Focusing on hDKC1, the essential and highly conserved
gene causative of X-linked dyskeratosis congenita, we found that
IR events characterize 3 new transcripts derived from this gene.
While 2 of them are essentially retained in the nucleus, one is
efﬁciently exported in the cytosol, is immune to NMD, and poten-
tially encodes a truncated protein able to play a novel interesting
biological role. As observed for another previously described
intron-retaining gene transcript (Angrisani et al. 2011), this new
isoform leads to exonize an intronic snoRNA, highlighting the
potential of IR events to link hDKC1 expression with that of its
hosted snoRNAs. Finally, expression of all hDKC1 multiple iso-
forms was found sensitive to differentiative stimuli, consistent
with the observation that IR can be speciﬁcally regulated (Mollet
et al. 2010). Considering that all new transcripts retain the ability
to encode for the canonical dyskerin N-terminal region, which
harbors a large group of pathogenic mutations, it is possible that
their expression might contribute to the clinical manifestations
of the disease and affect its phenotypic heterogeneity.
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